Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA6 SRCAP SSBP3 CREBBP KMT2C TSC22D1 SS18L1 DYRK1B NCOA1 SMARCD3 MAML2 RERE MED23 MED26 EP300	1.36e-08	303	154	15	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA6 SRCAP SSBP3 CREBBP YEATS2 NCOR1 KMT2C TSC22D1 SS18L1 DYRK1B NCOA1 SMARCD3 RCOR3 MAML2 RERE MED23 MED26 EP300	3.56e-07	562	154	18	GO:0003712
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA6 SGTA DAB2 NCK1 SRCAP SSBP3 CREBBP CRKL MSL2 YEATS2 NCOR1 KMT2C TSC22D1 SS18L1 DYRK1B NCOA1 SMARCD3 RCOR3 SLA2 MAML2 RERE MED23 MED26 BAG6 EP300 RAB11FIP3	1.44e-05	1356	154	26	GO:0060090
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA6 CREBBP NCOR1 EP300	1.84e-05	21	154	4	GO:0042975
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA6 DAB2 NCK1 SRCAP SSBP3 CREBBP CRKL YEATS2 NCOR1 KMT2C TSC22D1 SS18L1 DYRK1B NCOA1 SMARCD3 RCOR3 SLA2 MAML2 RERE MED23 MED26 EP300 RAB11FIP3	2.85e-05	1160	154	23	GO:0030674
GeneOntologyMolecularFunction	growth factor binding	ERBB2 ERBB4 ACVRL1 NRP1 LTBP2 KIT IL2RB IL9R	2.88e-05	156	154	8	GO:0019838
GeneOntologyMolecularFunction	chromatin binding	NCOA6 EP400 MAZ SREBF1 UPF1 MLLT10 CREBBP MSL2 NCOR1 TNRC18 MITF NCOA1 SMARCD3 RERE NFAT5 EP300 CRTC2	5.82e-05	739	154	17	GO:0003682
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	5.91e-05	2	154	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	5.91e-05	2	154	2	GO:0044017
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	1.76e-04	3	154	2	GO:0043993
GeneOntologyMolecularFunction	coreceptor activity	ERBB2 LILRB2 LILRB1 NRP1 IL2RB	2.36e-04	72	154	5	GO:0015026
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	ERBB2 ERBB4 ACVRL1 NRP1 KIT	5.11e-04	85	154	5	GO:0019199
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRB2 LILRB1	5.82e-04	5	154	2	GO:0030107
GeneOntologyMolecularFunction	histone acetyltransferase activity	SRCAP CREBBP NCOA1 EP300	6.41e-04	51	154	4	GO:0004402
GeneOntologyMolecularFunction	SH2 domain binding	LILRB2 LILRB1 SIGLEC10 KIT	6.91e-04	52	154	4	GO:0042169
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA6 NCOR1 NCOA1	7.11e-04	23	154	3	GO:0046965
GeneOntologyMolecularFunction	transcription factor binding	ATF7 NCOA6 SREBF1 CREBBP CRKL PGR YEATS2 NCOR1 UBN1 NCOA1 SMARCD3 NFAT5 EP300 TP53BP2 CRTC2	7.36e-04	753	154	15	GO:0008134
GeneOntologyMolecularFunction	transcription coregulator binding	ATF7 SREBF1 CREBBP PGR SMARCD3 EP300	7.66e-04	140	154	6	GO:0001221
GeneOntologyMolecularFunction	transcription coactivator binding	ATF7 CREBBP PGR EP300	7.97e-04	54	154	4	GO:0001223
GeneOntologyMolecularFunction	cytoskeletal protein binding	SHROOM3 CTTNBP2 BCL2L11 ABI3BP MAP4 SGK1 KNSTRN OBSCN EML3 FARP2 PTPRC FHOD1 KIF19 MACF1 EPS8L3 TNS1 UTRN EP300 EPB41	8.21e-04	1099	154	19	GO:0008092
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	SRCAP CREBBP NCOA1 EP300	8.55e-04	55	154	4	GO:0061733
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRB2 LILRB1	8.69e-04	6	154	2	GO:0030109
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	SRCAP CREBBP NCOA1 EP300	1.19e-03	60	154	4	GO:0034212
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRB2 LILRB1	1.21e-03	7	154	2	GO:0023025
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	ERBB2 ERBB4 NRP1 KIT	1.60e-03	65	154	4	GO:0004714
GeneOntologyMolecularFunction	mitogen-activated protein kinase binding	ATF7 MAPK7 EP300	2.46e-03	35	154	3	GO:0051019
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	EP400 CECR2 SRCAP	2.88e-03	37	154	3	GO:0140658
GeneOntologyMolecularFunction	IgM binding	LILRB2 LILRB1	3.11e-03	11	154	2	GO:0001791
GeneOntologyMolecularFunction	N-acetyltransferase activity	SRCAP CREBBP NCOA1 EP300	3.12e-03	78	154	4	GO:0008080
GeneOntologyMolecularFunction	protein kinase binding	ATF7 ERBB2 BCL2L11 SGK1 SREBF1 NCK1 ACVRL1 ITGAX CRKL NRP1 PTPRC MAPK7 UTRN EP300 ARHGAP33	3.12e-03	873	154	15	GO:0019901
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	ATF7 NCOA6 MAZ SREBF1 DAB2 NCK1 POGZ MLLT10 ACVRL1 SSBP3 LILRB1 CREBBP E2F8 PGR KMT2C TSC22D1 ZNF335 FHOD1 SS18L1 MITF NCOA1 MAML2 MAPK7 MED23 MED26 NFAT5 EP300 CRTC2	1.16e-06	1390	153	28	GO:0045944
GeneOntologyBiologicalProcess	embryo development	ATF7 NCOA6 ERBB4 SHROOM3 BCL2L11 CECR2 DAB2 CDH23 TNRC6C ACVRL1 SSBP3 CREBBP E2F8 NRP1 HOXA6 YEATS2 NCOR1 COL18A1 ZFP36L1 ZNF335 NCOA1 MACF1 MAPK7 KIT BAG6 EP300 TP53BP2 CRB2	2.22e-06	1437	153	28	GO:0009790
GeneOntologyBiologicalProcess	protein-DNA complex organization	EP400 CECR2 POGZ SRCAP CREBBP MSL2 YEATS2 NCOR1 KMT2C KANSL1 UBN1 ZNF335 SS18L1 NCOA1 SMARCD3 RERE MED23 MED26 NFAT5 BAG6 EP300	1.59e-05	999	153	21	GO:0071824
GeneOntologyBiologicalProcess	neuron development	HEXA ERBB2 ABI3BP MAP4 SGK1 CECR2 DAB2 CDH23 NCK1 PLXND1 NPHP4 CREBBP CRKL NRP1 FARP2 ATXN2 ZNF335 SS18L1 MACF1 TMEM108 RERE CNGB1 EP300 ARHGAP33 CRB2 OTOG	2.71e-05	1463	153	26	GO:0048666
GeneOntologyBiologicalProcess	cellular response to epidermal growth factor stimulus	ERBB2 ERBB4 KNSTRN DAB2 ZFP36L1	3.08e-05	49	153	5	GO:0071364
GeneOntologyBiologicalProcess	response to epidermal growth factor	ERBB2 ERBB4 KNSTRN DAB2 ZFP36L1	4.96e-05	54	153	5	GO:0070849
GeneOntologyBiologicalProcess	positive regulation of cell population proliferation	ERBB2 ERBB4 LILRB2 MAZ GPAM NCK1 ACVRL1 SSBP3 ITGAX CRKL PGR NRP1 NCOR1 COL18A1 KMT2C TSC22D1 THPO PTPRC ZNF335 SMARCD3 KIT INS-IGF2	6.85e-05	1190	153	22	GO:0008284
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	ZNF536 SGK1 DAB2 SSTR3 CRKL PGR NCOR1 NCOA1 EP300	8.90e-05	244	153	9	GO:0009755
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	ZNF536 BCL2L11 SGK1 SREBF1 DAB2 GPAM NCK1 SSTR3 CRKL PGR NCOR1 ZFP36L1 UMODL1 NCOA1 EP300 INS-IGF2	1.03e-04	727	153	16	GO:0032870
GeneOntologyBiologicalProcess	positive regulation of cell adhesion	ERBB2 ABI3BP LILRB2 DAB2 GPAM NCK1 LILRB1 CRKL NRP1 PTPRC SMARCD3 NFAT5 UTRN EP300	1.08e-04	579	153	14	GO:0045785
GeneOntologyBiologicalProcess	chromatin organization	EP400 CECR2 SRCAP CREBBP MSL2 YEATS2 NCOR1 KMT2C KANSL1 UBN1 ZNF335 SS18L1 NCOA1 SMARCD3 RERE NFAT5 BAG6 EP300	1.19e-04	896	153	18	GO:0006325
GeneOntologyBiologicalProcess	response to steroid hormone	BCL2L11 SGK1 SREBF1 DAB2 SSTR3 PGR NCOR1 PTPRC ZFP36L1 NCOA1 EP300	1.33e-04	381	153	11	GO:0048545
GeneOntologyBiologicalProcess	regulation of cell adhesion	ERBB2 ABI3BP LILRB2 DAB2 GPAM NCK1 PLXND1 ACVRL1 LILRB1 CRKL NRP1 PTPRC MACF1 SMARCD3 MAPK7 NFAT5 UTRN EP300	1.82e-04	927	153	18	GO:0030155
GeneOntologyBiologicalProcess	postsynaptic specialization organization	ABI3BP LILRB2 CRKL LRFN4 TMEM108	1.85e-04	71	153	5	GO:0099084
GeneOntologyBiologicalProcess	cellular response to transforming growth factor beta stimulus	DAB2 TNRC6C ACVRL1 CREBBP CRKL TSC22D1 ZFP36L1 LTBP2 MAPK7 EP300	2.11e-04	336	153	10	GO:0071560
GeneOntologyBiologicalProcess	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	DAB2 ACVRL1 CREBBP TSC22D1 EP300 CRB2	2.19e-04	115	153	6	GO:0090100
GeneOntologyBiologicalProcess	response to transforming growth factor beta	DAB2 TNRC6C ACVRL1 CREBBP CRKL TSC22D1 ZFP36L1 LTBP2 MAPK7 EP300	2.49e-04	343	153	10	GO:0071559
GeneOntologyBiologicalProcess	hemopoiesis	ATF7 NCOA6 ERBB2 LILRB2 DAB2 TNRC6C SSBP3 LILRB1 FARP2 NCOR1 TSC22D1 THPO PTPRC ZFP36L1 MITF SIGLEC10 SMARCD3 KIT EP300 CNOT4 IL9R	2.80e-04	1223	153	21	GO:0030097
GeneOntologyBiologicalProcess	cellular response to Thyroglobulin triiodothyronine	NCOR1 NCOA1	3.25e-04	4	153	2	GO:1904017
GeneOntologyBiologicalProcess	granulosa cell apoptotic process	PGR UMODL1	3.25e-04	4	153	2	GO:1904700
GeneOntologyBiologicalProcess	regulation of granulosa cell apoptotic process	PGR UMODL1	3.25e-04	4	153	2	GO:1904708
GeneOntologyBiologicalProcess	N-terminal peptidyl-lysine acetylation	CREBBP EP300	3.25e-04	4	153	2	GO:0018076
GeneOntologyBiologicalProcess	lymphocyte activation	ERBB2 LILRB2 GPAM NCK1 ITGAX LILRB1 NCOR1 PTPRC ZFP36L1 ZNF335 SIGLEC10 SMARCD3 SLA2 KIT BAG6 EP300 INS-IGF2 IL9R	3.40e-04	976	153	18	GO:0046649
GeneOntologyBiologicalProcess	positive regulation of response to endoplasmic reticulum stress	BCL2L11 SGTA NCK1 BAG6	3.42e-04	45	153	4	GO:1905898
GeneOntologyCellularComponent	chromatin	ATF7 NCAPD3 ZBTB33 EP400 CECR2 SREBF1 ADNP2 POGZ UPF1 SRCAP CREBBP E2F8 PGR MSL2 HOXA6 YEATS2 NCOR1 KANSL1 ZFHX4 SS18L1 MITF ZFHX2 NCOA1 SMARCD3 PAX4 NFAT5 EP300	1.32e-05	1480	156	27	GO:0000785
GeneOntologyCellularComponent	histone acetyltransferase complex	EP400 CREBBP MSL2 YEATS2 KANSL1 EP300	7.43e-05	94	156	6	GO:0000123
GeneOntologyCellularComponent	semaphorin receptor complex	ERBB2 PLXND1 NRP1	1.10e-04	13	156	3	GO:0002116
GeneOntologyCellularComponent	protein acetyltransferase complex	EP400 CREBBP MSL2 YEATS2 KANSL1 EP300	1.30e-04	104	156	6	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	EP400 CREBBP MSL2 YEATS2 KANSL1 EP300	1.69e-04	109	156	6	GO:1902493
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	EP400 MSL2 YEATS2 KANSL1	3.50e-04	45	156	4	GO:1902562
GeneOntologyCellularComponent	histone deacetylase complex	EP400 SRCAP NCOR1 RCOR3 RERE	4.40e-04	85	156	5	GO:0000118
GeneOntologyCellularComponent	transcription regulator complex	ATF7 NCOA6 SSBP3 CREBBP E2F8 NCOR1 NCOA1 RCOR3 PAX4 MED23 MED26 NFAT5 EP300	5.44e-04	596	156	13	GO:0005667
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	EP400 CECR2 SRCAP SS18L1 SMARCD3	7.68e-04	96	156	5	GO:0070603
HumanPheno	Abnormal subclavian artery morphology	KNSTRN PLXND1 CREBBP EP300	3.02e-06	11	52	4	HP:0031251
MousePheno	abnormal ventricle myocardium morphology	NCOA6 ERBB2 ERBB4 SHROOM3 PLXND1 ACVRL1 CREBBP ZFP36L1 MAPK7 EP300	1.40e-07	116	132	10	MP:0010499
MousePheno	abnormal myocardium compact layer morphology	NCOA6 SHROOM3 CREBBP SMARCD3 MAPK7 NFAT5 EP300	3.10e-06	67	132	7	MP:0004056
MousePheno	lethality throughout fetal growth and development	NCOA6 MAZ SREBF1 POGZ SSBP3 CREBBP CRKL NCOR1 BTBD7 SMARCD3 MED23 NFAT5 KIT BAG6 EP300 CNOT4	3.38e-06	435	132	16	MP:0006208
MousePheno	abnormal trabecula carnea morphology	NCOA6 ERBB2 ERBB4 ACVRL1 ZFP36L1 MAPK7 EP300	8.63e-06	78	132	7	MP:0004067
MousePheno	abnormal myocardial trabeculae morphology	NCOA6 ERBB2 ERBB4 ACVRL1 ZFP36L1 SMARCD3 MAPK7 NFAT5 EP300	8.81e-06	144	132	9	MP:0002189
MousePheno	increased circulating ketone body level	ACACB SREBF1 GPAM NCOR1 INS-IGF2	3.10e-05	39	132	5	MP:0002575
MousePheno	ketosis	ACACB SREBF1 GPAM NCOR1 INS-IGF2	5.02e-05	43	132	5	MP:0030970
MousePheno	heart hypoplasia	NCOA6 SHROOM3 ACVRL1 CREBBP ZFP36L1 MAPK7 EP300	5.33e-05	103	132	7	MP:0002740
MousePheno	ventricle myocardium hypoplasia	NCOA6 SHROOM3 CREBBP ZFP36L1 MAPK7 EP300	5.48e-05	71	132	6	MP:0010502
MousePheno	thin myocardium compact layer	NCOA6 SHROOM3 CREBBP SMARCD3 EP300	6.99e-05	46	132	5	MP:0004057
MousePheno	abnormal iris stromal pigmentation	COL18A1 MITF	8.85e-05	2	132	2	MP:0005541
MousePheno	abnormal intersomitic vessel morphology	PLXND1 ACVRL1 ZFP36L1 MAPK7	1.50e-04	29	132	4	MP:0012253
MousePheno	abnormal circulating ketone body level	ACACB SREBF1 GPAM NCOR1 INS-IGF2	1.52e-04	54	132	5	MP:0003457
MousePheno	lethality throughout fetal growth and development, incomplete penetrance	MAZ SREBF1 POGZ SSBP3 CREBBP BTBD7 NFAT5 BAG6 EP300	1.57e-04	208	132	9	MP:0011109
MousePheno	myocardium hypoplasia	NCOA6 SHROOM3 CREBBP ZFP36L1 MAPK7 EP300	1.60e-04	86	132	6	MP:0010500
MousePheno	abnormal megakaryocyte morphology	CREBBP CBLIF THPO KIT ARHGAP21 EP300	1.60e-04	86	132	6	MP:0002417
MousePheno	ventricular septal defect	SHROOM3 POGZ PLXND1 CREBBP CRKL SMARCD3 RERE MAPK7 EP300 TP53BP2	1.83e-04	261	132	10	MP:0010402
MousePheno	embryonic lethality during organogenesis	NCOA6 ERBB2 ERBB4 BCL2L11 EP400 SREBF1 DAB2 POGZ ACVRL1 SSBP3 CREBBP NRP1 ZFP36L1 SMARCD3 RERE MAPK7 MED23 KIT EP300 CRB2	2.04e-04	876	132	20	MP:0006207
MousePheno	abnormal heart development	NCOA6 ERBB2 ERBB4 SHROOM3 ACVRL1 CREBBP ZFP36L1 SMARCD3 RERE MAPK7 EP300 CRB2	2.09e-04	372	132	12	MP:0000267
MousePheno	absent trabeculae carneae	ERBB2 ERBB4 EP300	2.20e-04	13	132	3	MP:0000296
MousePheno	absent strial intermediate cells	MITF KIT	2.64e-04	3	132	2	MP:0006010
MousePheno	decreased CD8-positive, alpha-beta memory T cell number	PTPRC ZNF335 SIGLEC10 IL2RB	2.83e-04	34	132	4	MP:0010839
MousePheno	abnormal heart septum morphology	SHROOM3 POGZ PLXND1 CREBBP CRKL NRP1 SMARCD3 RERE MAPK7 EP300 INS-IGF2 TP53BP2	3.07e-04	388	132	12	MP:0006113
MousePheno	abnormal response to transplant	LILRB2 LILRB1 KIT IL2RB INS-IGF2	3.40e-04	64	132	5	MP:0005671
MousePheno	ventricular hypoplasia	NCOA6 SHROOM3 CREBBP ZFP36L1 MAPK7 EP300	3.46e-04	99	132	6	MP:0000279
MousePheno	abnormal auditory brainstem response	SECISBP2L MAZ KLHDC7B CDH23 MLLT10 NRP1 DYRK1B MITF RCOR3 TMEM108 RERE KIT ARHGAP21 OTOG RAB11FIP3	3.50e-04	576	132	15	MP:0004738
MousePheno	abnormal blood cell morphology/development	NCOA6 CTTNBP2 BCL2L11 EP400 LILRB2 POGZ ACVRL1 ITGAX LILRB1 CREBBP CBLIF NCOR1 PTPRC ZFP36L1 ZNF335 SIGLEC10 NFAT5 KIT IL2RB EP300 EPB41	3.59e-04	986	132	21	MP:0002429
MousePheno	abnormal vitelline vasculature morphology	NCOA6 ERBB2 ACVRL1 CREBBP NRP1 ZFP36L1 MAPK7 EP300 CRB2	3.89e-04	235	132	9	MP:0003229
MousePheno	abnormal interventricular septum morphology	SHROOM3 POGZ PLXND1 CREBBP CRKL SMARCD3 RERE MAPK7 EP300 INS-IGF2 TP53BP2	3.96e-04	342	132	11	MP:0000281
MousePheno	abnormal bone marrow hematopoietic cell morphology	CREBBP CBLIF THPO KIT ARHGAP21 EP300	4.06e-04	102	132	6	MP:0013660
MousePheno	abnormal visual cortex morphology	LILRB2 LILRB1 ARHGAP33	4.21e-04	16	132	3	MP:0000805
MousePheno	increased pancreatic beta cell number	PGR ATXN2 INS-IGF2	4.21e-04	16	132	3	MP:0003645
MousePheno	abnormal neural tube morphology	ERBB2 SHROOM3 EP400 CECR2 MLLT10 SSBP3 CREBBP CRKL ZFP36L1 RERE MED23 KIT EP300 TP53BP2 CRB2	4.58e-04	591	132	15	MP:0002151
MousePheno	abnormal heart ventricle morphology	NCOA6 ERBB2 ERBB4 SHROOM3 POGZ PLXND1 ACVRL1 CREBBP CRKL NCOR1 ZFP36L1 SMARCD3 RERE MAPK7 NFAT5 EP300 INS-IGF2 TP53BP2	4.68e-04	793	132	18	MP:0005294
MousePheno	abnormal hearing electrophysiology	SECISBP2L MAZ KLHDC7B CDH23 MLLT10 NRP1 DYRK1B MITF RCOR3 TMEM108 RERE KIT ARHGAP21 OTOG RAB11FIP3	4.83e-04	594	132	15	MP:0006335
MousePheno	abnormal epicardium morphology	NCOA6 ZFP36L1 EP300	5.08e-04	17	132	3	MP:0003057
MousePheno	abnormal epicardium development	ZFP36L1 EP300	5.24e-04	4	132	2	MP:0031590
MousePheno	abnormal cardiovascular development	NCOA6 ERBB2 ERBB4 SHROOM3 RNF213 PLXND1 ACVRL1 CREBBP NRP1 ZFP36L1 ARHGAP31 SMARCD3 RERE MAPK7 MED23 EP300 TP53BP2 CRB2	5.35e-04	802	132	18	MP:0002925
MousePheno	abnormal myocardium layer morphology	NCOA6 ERBB2 ERBB4 SHROOM3 PLXND1 ACVRL1 CREBBP ZFP36L1 SMARCD3 MAPK7 NFAT5 EP300	5.50e-04	414	132	12	MP:0005329
MousePheno	abnormal vascular development	NCOA6 ERBB2 RNF213 PLXND1 ACVRL1 CREBBP NRP1 ZFP36L1 ARHGAP31 MAPK7 MED23 EP300 TP53BP2 CRB2	6.01e-04	542	132	14	MP:0000259
MousePheno	abnormal occipital lobe morphology	LILRB2 LILRB1 ARHGAP33	6.05e-04	18	132	3	MP:0000804
MousePheno	anemia	EP400 POGZ CREBBP NCOR1 ZFP36L1 NFAT5 KIT IL2RB EP300 EPB41	6.46e-04	306	132	10	MP:0001577
MousePheno	abnormal nervous system development	NCOA6 ERBB2 ERBB4 SHROOM3 SYN3 EP400 CECR2 MLLT10 SSBP3 CREBBP CRKL NRP1 COL18A1 ZFP36L1 KIF19 NCOA1 RERE MAPK7 MED23 KIT BAG6 EP300 TP53BP2 CRB2	6.48e-04	1257	132	24	MP:0003861
MousePheno	abnormal heart layer morphology	NCOA6 ERBB2 ERBB4 SHROOM3 PLXND1 ACVRL1 CREBBP ZFP36L1 SMARCD3 MAPK7 NFAT5 EP300	6.51e-04	422	132	12	MP:0010545
MousePheno	abnormal plasma cell morphology	CTTNBP2 BCL2L11 PTPRC SIGLEC10 IL2RB	7.08e-04	75	132	5	MP:0002439
MousePheno	abnormal cardiac muscle tissue morphology	NCOA6 ERBB2 ERBB4 SHROOM3 PLXND1 ACVRL1 CREBBP ZFP36L1 SMARCD3 MAPK7 NFAT5 EP300 INS-IGF2	7.27e-04	489	132	13	MP:0010630
MousePheno	thin ventricle myocardium compact layer	SHROOM3 CREBBP EP300	8.34e-04	20	132	3	MP:0010556
MousePheno	increased megakaryocyte cell number	CREBBP KIT ARHGAP21 EP300	8.39e-04	45	132	4	MP:0008254
Domain	Nuc_rcpt_coact	CREBBP NCOA1 EP300	9.58e-06	6	148	3	IPR009110
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	6.24e-05	2	148	2	IPR014744
Domain	ZnF_TAZ	CREBBP EP300	6.24e-05	2	148	2	SM00551
Domain	-	CREBBP EP300	6.24e-05	2	148	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	6.24e-05	2	148	2	IPR010303
Domain	-	CREBBP EP300	6.24e-05	2	148	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	6.24e-05	2	148	2	PF09030
Domain	zf-TAZ	CREBBP EP300	6.24e-05	2	148	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	6.24e-05	2	148	2	PS50134
Domain	KAT11	CREBBP EP300	6.24e-05	2	148	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	6.24e-05	2	148	2	IPR000197
Domain	KIX	CREBBP EP300	6.24e-05	2	148	2	PF02172
Domain	HAT_KAT11	CREBBP EP300	6.24e-05	2	148	2	PF08214
Domain	KIX	CREBBP EP300	6.24e-05	2	148	2	PS50952
Domain	CBP_P300_HAT	CREBBP EP300	6.24e-05	2	148	2	IPR031162
Domain	DUF902	CREBBP EP300	6.24e-05	2	148	2	PF06001
Domain	-	CREBBP EP300	6.24e-05	2	148	2	1.10.246.20
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	6.24e-05	2	148	2	IPR013178
Domain	KIX_dom	CREBBP EP300	6.24e-05	2	148	2	IPR003101
Domain	CBP_P300_HAT	CREBBP EP300	6.24e-05	2	148	2	PS51727
Domain	MYB_LIKE	EP400 NCOR1 RCOR3 RERE	2.27e-04	38	148	4	PS50090
Domain	Homeodomain-like	EP400 ADNP2 POGZ HOXA6 NCOR1 ZFHX4 ZFHX2 RCOR3 PAX4 RERE	3.21e-04	332	148	10	IPR009057
Domain	SH3	OBSCN NCK1 CRKL MACF1 SLA2 EPS8L3 ARHGAP33 TP53BP2	3.31e-04	216	148	8	PS50002
Domain	ZF_ZZ_2	CREBBP UTRN EP300	3.65e-04	18	148	3	PS50135
Domain	ZF_ZZ_1	CREBBP UTRN EP300	3.65e-04	18	148	3	PS01357
Domain	ZZ	CREBBP UTRN EP300	3.65e-04	18	148	3	PF00569
Domain	HSA	EP400 SRCAP	3.70e-04	4	148	2	SM00573
Domain	HSA	EP400 SRCAP	3.70e-04	4	148	2	PS51204
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 ERBB4	3.70e-04	4	148	2	IPR016245
Domain	HSA_dom	EP400 SRCAP	3.70e-04	4	148	2	IPR014012
Domain	HSA	EP400 SRCAP	3.70e-04	4	148	2	PF07529
Domain	SH3_domain	OBSCN NCK1 CRKL MACF1 SLA2 EPS8L3 ARHGAP33 TP53BP2	3.75e-04	220	148	8	IPR001452
Domain	Znf_ZZ	CREBBP UTRN EP300	4.30e-04	19	148	3	IPR000433
Domain	ZnF_ZZ	CREBBP UTRN EP300	4.30e-04	19	148	3	SM00291
Domain	SANT	EP400 NCOR1 RCOR3 RERE	6.57e-04	50	148	4	SM00717
Domain	SANT/Myb	EP400 NCOR1 RCOR3 RERE	7.63e-04	52	148	4	IPR001005
Domain	GF_recep_IV	ERBB2 ERBB4	9.16e-04	6	148	2	PF14843
Domain	GF_recep_IV	ERBB2 ERBB4	9.16e-04	6	148	2	IPR032778
Domain	FN3	ABI3BP OBSCN LRFN4 PTPRC UMODL1 IL2RB IL9R	1.06e-03	199	148	7	PS50853
Domain	SANT_dom	NCOR1 RCOR3 RERE	1.11e-03	26	148	3	IPR017884
Domain	Bromodomain_CS	CECR2 CREBBP EP300	1.11e-03	26	148	3	IPR018359
Domain	Recep_L_domain	ERBB2 ERBB4	1.28e-03	7	148	2	PF01030
Domain	Furin-like	ERBB2 ERBB4	1.28e-03	7	148	2	PF00757
Domain	Rcpt_L-dom	ERBB2 ERBB4	1.28e-03	7	148	2	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB2 ERBB4	1.28e-03	7	148	2	IPR006211
Domain	-	ERBB2 ERBB4	1.28e-03	7	148	2	3.80.20.20
Domain	SANT	NCOR1 RCOR3 RERE	1.38e-03	28	148	3	PS51293
Domain	FN3_dom	ABI3BP OBSCN LRFN4 PTPRC UMODL1 IL2RB IL9R	1.40e-03	209	148	7	IPR003961
Domain	Ig-like_fold	ADAMTSL1 ABI3BP LILRB2 OBSCN PLXND1 LILRB1 LRFN4 PTPRC UMODL1 SIGLEC10 NFAT5 KIT IL2RB IL9R	1.48e-03	706	148	14	IPR013783
Domain	PTB	EPS8L3 TNS1	1.69e-03	8	148	2	IPR013625
Domain	HEMATOPO_REC_S_F1	IL2RB IL9R	1.69e-03	8	148	2	PS01355
Domain	PTB	EPS8L3 TNS1	1.69e-03	8	148	2	PF08416
Domain	SH3	OBSCN NCK1 CRKL SLA2 EPS8L3 ARHGAP33 TP53BP2	1.70e-03	216	148	7	SM00326
Domain	HMGI/Y_DNA-bd_CS	CECR2 KMT2C PRB1	1.86e-03	31	148	3	IPR000637
Domain	SH3_1	NCK1 CRKL SLA2 EPS8L3 ARHGAP33 TP53BP2	1.98e-03	164	148	6	PF00018
Domain	Hempt_rcpt_S_F1_CS	IL2RB IL9R	2.16e-03	9	148	2	IPR003531
Domain	-	ADAMTSL1 ABI3BP OBSCN PLXND1 LILRB1 LRFN4 PTPRC UMODL1 SIGLEC10 NFAT5 KIT IL2RB IL9R	2.40e-03	663	148	13	2.60.40.10
Domain	Myb_DNA-binding	NCOR1 RCOR3 RERE	2.65e-03	35	148	3	PF00249
Domain	BROMODOMAIN_1	CECR2 CREBBP EP300	3.11e-03	37	148	3	PS00633
Domain	BAH	TNRC18 RERE	3.27e-03	11	148	2	PS51038
Domain	BAH_dom	TNRC18 RERE	3.27e-03	11	148	2	IPR001025
Domain	BAH	TNRC18 RERE	3.27e-03	11	148	2	SM00439
Domain	BAH	TNRC18 RERE	3.27e-03	11	148	2	PF01426
Domain	Protein_kinase_ATP_BS	ERBB2 ERBB4 SGK1 CDK19 OBSCN ACVRL1 DYRK1B MAPK7 KIT	3.28e-03	379	148	9	IPR017441
Domain	Bromodomain	CECR2 CREBBP EP300	3.36e-03	38	148	3	PF00439
Domain	FN3	ABI3BP OBSCN LRFN4 PTPRC UMODL1 IL2RB	3.60e-03	185	148	6	SM00060
Domain	PROTEIN_KINASE_ATP	ERBB2 ERBB4 SGK1 CDK19 OBSCN ACVRL1 DYRK1B MAPK7 KIT WNK2	3.64e-03	459	148	10	PS00107
Domain	C8	SSPOP OTOG	3.91e-03	12	148	2	PF08742
Domain	TIL	SSPOP OTOG	3.91e-03	12	148	2	PF01826
Domain	Kinase-like_dom	ERBB2 ERBB4 SGK1 CDK19 OBSCN ACVRL1 DYRK1B MACF1 MAPK7 KIT WNK2	3.98e-03	542	148	11	IPR011009
Domain	BROMODOMAIN_2	CECR2 CREBBP EP300	4.17e-03	41	148	3	PS50014
Domain	Bromodomain	CECR2 CREBBP EP300	4.46e-03	42	148	3	IPR001487
Domain	BROMO	CECR2 CREBBP EP300	4.46e-03	42	148	3	SM00297
Domain	-	CECR2 CREBBP EP300	4.46e-03	42	148	3	1.20.920.10
Domain	ELM2_dom	RCOR3 RERE	4.59e-03	13	148	2	IPR000949
Domain	FA	FARP2 EPB41	4.59e-03	13	148	2	PF08736
Domain	-	ACACB SYN3	4.59e-03	13	148	2	3.40.50.20
Domain	FERM-adjacent	FARP2 EPB41	4.59e-03	13	148	2	IPR014847
Domain	Unchr_dom_Cys-rich	SSPOP OTOG	4.59e-03	13	148	2	IPR014853
Domain	ELM2	RCOR3 RERE	4.59e-03	13	148	2	PF01448
Domain	C8	SSPOP OTOG	4.59e-03	13	148	2	SM00832
Domain	ELM2	RCOR3 RERE	4.59e-03	13	148	2	PS51156
Domain	FA	FARP2 EPB41	4.59e-03	13	148	2	SM01195
Domain	ELM2	RCOR3 RERE	4.59e-03	13	148	2	SM01189
Domain	Rho_GTPase_activation_prot	PLXND1 ARHGAP31 ARHGAP21 ARHGAP33	5.28e-03	88	148	4	IPR008936
Domain	TIL_dom	SSPOP OTOG	5.33e-03	14	148	2	IPR002919
Domain	PreATP-grasp_dom	ACACB SYN3	5.33e-03	14	148	2	IPR016185
Domain	Prot_kinase_dom	ERBB2 ERBB4 SGK1 CDK19 OBSCN ACVRL1 DYRK1B MAPK7 KIT WNK2	5.65e-03	489	148	10	IPR000719
Domain	PROTEIN_KINASE_DOM	ERBB2 ERBB4 SGK1 CDK19 OBSCN ACVRL1 DYRK1B MAPK7 KIT WNK2	5.98e-03	493	148	10	PS50011
Domain	-	ACACB SYN3	6.12e-03	15	148	2	3.30.1490.20
Domain	VWF_type-D	SSPOP OTOG	6.96e-03	16	148	2	IPR001846
Domain	VWFD	SSPOP OTOG	6.96e-03	16	148	2	PS51233
Domain	AT_hook	CECR2 KMT2C	6.96e-03	16	148	2	PF02178
Domain	VWD	SSPOP OTOG	6.96e-03	16	148	2	SM00216
Domain	VWD	SSPOP OTOG	6.96e-03	16	148	2	PF00094
Domain	PROTEIN_KINASE_TYR	ERBB2 ERBB4 OBSCN KIT	7.42e-03	97	148	4	PS00109
Domain	Tyr_kinase_AS	ERBB2 ERBB4 OBSCN KIT	7.42e-03	97	148	4	IPR008266
Domain	-	POGZ HOXA6 NCOR1 ZFHX4 ZFHX2 RCOR3 PAX4	7.44e-03	283	148	7	1.10.10.60
Domain	EMI	SSPOP UMODL1	7.85e-03	17	148	2	PS51041
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA6 CDK19 SREBF1 CREBBP NCOR1 NCOA1 SMARCD3 MED23 MED26 EP300	1.34e-09	84	114	10	M1008
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA6 SREBF1 CREBBP NCOA1 SMARCD3 EP300	4.20e-09	18	114	6	M26942
Pathway	REACTOME_ADIPOGENESIS	NCOA6 CDK19 SREBF1 CREBBP NCOR1 NCOA1 SMARCD3 MED23 MED26 EP300	1.91e-08	110	114	10	M48259
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA6 CDK19 SREBF1 CREBBP NCOR1 NCOA1 SMARCD3 MED23 MED26 EP300	3.76e-08	118	114	10	M27316
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA6 ACACB SREBF1 GPAM CREBBP NCOA1 SMARCD3	4.01e-08	42	114	7	M27172
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA6 SREBF1 CREBBP NCOR1 NCOA1 SMARCD3 EP300 CRTC2	8.88e-08	70	114	8	M938
Pathway	REACTOME_HEME_SIGNALING	NCOA6 CREBBP NCOR1 NCOA1 SMARCD3 EP300 CRTC2	1.22e-07	49	114	7	M41832
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA6 ACACB SREBF1 GPAM CREBBP NCOA1 SMARCD3	2.77e-07	55	114	7	M27001
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	NCOA6 ERBB2 TUT4 CDK19 SREBF1 NCK1 PLXND1 TNRC6C CREBBP NRP1 FARP2 HOXA6 NCOR1 KMT2C TSC22D1 PTPRC ZNF335 SS18L1 MITF NCOA1 SMARCD3 PAX4 MAML2 MAPK7 MED23 MED26 KIT UTRN EP300 CNOT4	7.20e-07	1432	114	30	M509
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ERBB2 SRCAP CREBBP NCOR1 KMT2C KANSL1 EP300	8.88e-07	65	114	7	M39682
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA6 CREBBP NCOR1 NCOA1 SMARCD3 CRTC2	5.14e-06	55	114	6	M27145
Pathway	BIOCARTA_MELANOCYTE_PATHWAY	MITF KIT EP300	1.76e-05	7	114	3	M22035
Pathway	BIOCARTA_MELANOCYTE_PATHWAY	MITF KIT EP300	1.76e-05	7	114	3	MM1555
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP NCOA1 EP300	2.80e-05	8	114	3	M22058
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	NCOA6 MCHR1 SSTR3 NPHP4 CREBBP NCOR1 NCOA1 SMARCD3 CNGB1 CRTC2 RAB11FIP3	2.83e-05	297	114	11	M27050
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	SREBF1 TNRC6C NCOR1 NCOA1 EP300	3.70e-05	47	114	5	M29777
Pathway	BIOCARTA_VDR_PATHWAY	CREBBP NCOR1 NCOA1 EP300	3.80e-05	24	114	4	M13404
Pathway	PID_HES_HEY_PATHWAY	CREBBP NCOR1 NCOA1 MAML2 EP300	4.11e-05	48	114	5	M288
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	PLXND1 CREBBP MAML2 EP300	4.50e-05	25	114	4	M27880
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	ERBB2 PLXND1 NRP1 FARP2 PTPRC	5.53e-05	51	114	5	MM14967
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA6 CREBBP NCOA1 SMARCD3	6.17e-05	27	114	4	M26943
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	EP400 CREBBP MSL2 YEATS2 NCOR1 KMT2C KANSL1 NCOA1 SMARCD3 EP300	7.07e-05	272	114	10	M29619
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOA6 CREBBP NCOR1 NCOA1 SMARCD3	1.21e-04	60	114	5	M41830
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	NCOA6 CREBBP NCOR1 NCOA1 SMARCD3 CRTC2	1.26e-04	96	114	6	M26973
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	EP400 CREBBP MSL2 YEATS2 KANSL1 NCOA1 EP300	1.52e-04	142	114	7	M27233
Pathway	PID_ERA_GENOMIC_PATHWAY	PGR NCOR1 COL18A1 NCOA1 EP300	1.65e-04	64	114	5	M200
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	ERBB2 PLXND1 NRP1 FARP2 PTPRC	1.65e-04	64	114	5	M7923
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	CREBBP MAML2 EP300	1.76e-04	14	114	3	M27808
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	ERBB4 GPAM TNRC6C CREBBP PGR NCOA1 EP300	2.05e-04	149	114	7	M27888
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	TNRC6C NCOR1 NCOA1 EP300	2.18e-04	37	114	4	M29790
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS	ERBB2 CREBBP KIT EP300	2.42e-04	38	114	4	M27757
Pathway	REACTOME_METABOLISM_OF_STEROIDS	NCOA6 ACACB SREBF1 GPAM CREBBP NCOA1 SMARCD3	2.51e-04	154	114	7	M27832
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	CREBBP MAML2 EP300	2.67e-04	16	114	3	M27121
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	BCL2L11 CREBBP EP300	2.67e-04	16	114	3	M27940
Pathway	REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE	MCHR1 SSTR3 CNGB1 RAB11FIP3	2.68e-04	39	114	4	MM15209
Pathway	REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA	TUT4 CREBBP EP300	3.22e-04	17	114	3	M48025
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	CREBBP PAX4 MAML2 EP300	3.58e-04	42	114	4	M17541
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	NCOA6 YEATS2 KMT2C KANSL1	3.58e-04	42	114	4	M48018
Pathway	WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING	CREBBP PTPRC MAPK7 IL2RB IL9R	4.18e-04	78	114	5	M39824
Pathway	REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	NCOA6 CREBBP NCOR1 KMT2C ZNF335 EP300	4.63e-04	122	114	6	M29689
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	CREBBP MAML2 EP300	5.31e-04	20	114	3	M27881
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	CREBBP NCOR1 MAML2 EP300	6.00e-04	48	114	4	M611
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	6.38e-04	5	114	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	6.38e-04	5	114	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	6.38e-04	5	114	2	M48023
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	6.38e-04	5	114	2	M27228
Pathway	REACTOME_SIGNALING_BY_NOTCH3	PLXND1 CREBBP MAML2 EP300	6.49e-04	49	114	4	M618
Pathway	PID_FOXO_PATHWAY	BCL2L11 SGK1 CREBBP EP300	6.49e-04	49	114	4	M136
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	ERBB4 SREBF1 GPAM TNRC6C CREBBP PGR NCOR1 NCOA1 EP300	6.63e-04	296	114	9	M27869
Pathway	BIOCARTA_VDR_PATHWAY	CREBBP NCOR1 EP300	7.09e-04	22	114	3	MM1370
Pathway	REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE	MCHR1 SSTR3 CNGB1 RAB11FIP3	7.56e-04	51	114	4	M27480
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EP300	8.11e-04	23	114	3	MM1480
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EP300	8.11e-04	23	114	3	M18719
Pathway	PID_KIT_PATHWAY	CREBBP CRKL MITF KIT	8.14e-04	52	114	4	M231
Pathway	BIOCARTA_PPARA_PATHWAY	CREBBP NCOR1 NCOA1 EP300	8.14e-04	52	114	4	M2404
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	TNRC6C CREBBP SS18L1 MITF SMARCD3 KIT	8.53e-04	137	114	6	M48232
Pathway	WP_ERBB_SIGNALING	ERBB2 ERBB4 BCL2L11 NCK1 CRKL	8.90e-04	92	114	5	M39715
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	9.52e-04	6	114	2	M22062
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	ERBB2 ERBB4 KIT	1.04e-03	25	114	3	M47934
Pathway	REACTOME_RSV_HOST_INTERACTIONS	CDK19 CREBBP MED23 MED26 EP300	1.18e-03	98	114	5	M48247
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	CREBBP NCOR1 MAML2 EP300	1.23e-03	58	114	4	M29616
Pathway	WP_IL6_SIGNALING_PATHWAY	ERBB2 SGK1 CREBBP NCOA1 EP300	1.29e-03	100	114	5	MM15826
Pathway	WP_KIT_RECEPTOR_SIGNALING	CRKL MITF KIT EP300	1.31e-03	59	114	4	M39350
Pathway	PID_NOTCH_PATHWAY	SSPOP NCOR1 MAML2 EP300	1.31e-03	59	114	4	M17
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	1.33e-03	7	114	2	MM1573
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	CREBBP NCOR1 MAML2	1.46e-03	28	114	3	M6177
Pathway	WP_KLEEFSTRA_SYNDROME	NCOA6 KMT2C SMARCD3	1.61e-03	29	114	3	M48076
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	ERBB4 PGR NCOA1 EP300	1.67e-03	63	114	4	MM15613
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	1.76e-03	8	114	2	M48022
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	CREBBP EP300	1.76e-03	8	114	2	M48024
Pathway	REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES	CREBBP EP300	1.76e-03	8	114	2	M46443
Pathway	PID_RETINOIC_ACID_PATHWAY	CREBBP NCOA1 EP300	1.78e-03	30	114	3	M207
Pathway	PID_RB_1PATHWAY	ATF7 CREBBP MITF EP300	1.88e-03	65	114	4	M279
Pathway	PID_HDAC_CLASSI_PATHWAY	SSPOP CREBBP NCOR1 EP300	1.99e-03	66	114	4	M101
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	BCL2L11 SREBF1 CREBBP EP300	1.99e-03	66	114	4	M27938
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	ERBB4 GPAM TNRC6C CREBBP PGR NCOA1 EP300	2.06e-03	220	114	7	M27794
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	ERBB2 ERBB4 SGK1 NCK1 CRKL NRP1 MAPK7 KIT EP300 INS-IGF2	2.06e-03	418	114	10	MM15587
Pathway	WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING	ACACB SREBF1 INS-IGF2 CRTC2	2.10e-03	67	114	4	M39630
Pathway	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	ERBB4 PGR NCOR1	2.15e-03	32	114	3	M571
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	NRP1 FARP2	2.25e-03	9	114	2	MM15030
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	NCOR1 NCOA1	2.25e-03	9	114	2	M29809
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	CREBBP EP300	2.25e-03	9	114	2	M47451
Pathway	WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4	ERBB2 ERBB4 PGR	2.35e-03	33	114	3	M39455
Pathway	WP_KIT_RECEPTOR_SIGNALING_PATHWAY	CRKL MITF KIT EP300	2.60e-03	71	114	4	MM15947
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 EP300	2.80e-03	10	114	2	MM15535
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	CREBBP EP300	2.80e-03	10	114	2	M27945
Pathway	KEGG_ADHERENS_JUNCTION	ERBB2 CREBBP FARP2 EP300	2.88e-03	73	114	4	M638
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY	CDK19 CREBBP MED23 MED26 EP300	2.89e-03	120	114	5	M48233
Pathway	REACTOME_SIGNALING_BY_NOTCH1	CREBBP NCOR1 MAML2 EP300	3.02e-03	74	114	4	M616
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 ERBB4 SHROOM3 ACACB EP400 DAB2 MLLT10 MAGEE1 NCOR1 TNRC18 UBN1 ATXN2 ARHGAP31 MITF SLA2 MAML2 PRRC1 WNK2 TP53BP2 CRTC2	9.15e-15	430	157	20	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HEXA NCOA6 ERBB2 SHROOM3 BCL2L11 EP400 OBSCN SREBF1 PPP6R1 PLXND1 TNRC6C MLLT10 SRCAP NPHP4 EML3 RABL6 ZCCHC14 NCOR1 KMT2C TNRC18 KANSL1 UBN1 BTBD7 ZNF335 ARHGAP21 EP300 WNK2 ARHGAP33 RAB11FIP3	1.79e-14	1105	157	29	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATF7 EP400P1 ERBB2 SHROOM3 TUT4 MAP4 SGTA CDK19 OBSCN ZDHHC14 RNF213 IQCN TNRC6C SSBP3 SSPOP CREBBP NRP1 FARP2 YEATS2 COL18A1 KMT2C TSC22D1 TNRC18 ATXN2 ZFHX2 MACF1 RCOR3 RERE NFAT5 UTRN EP300 EPB41 WNK2	2.58e-14	1489	157	33	28611215
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 ZNF536 ACACB EP400 PROSER1 POGZ CREBBP NCOR1 KMT2C TNRC18 ZFHX4 SS18L1 MITF NCOA1 SMARCD3 RERE EP300	5.41e-13	351	157	17	38297188
Pubmed	A human MAP kinase interactome.	ABI3BP DAB2 ADNP2 POGZ CREBBP MSL2 LENG8 KMT2C TSC22D1 KANSL1 ARHGAP31 FHOD1 DYRK1B MACF1 MAPK7 TNS1 EP300 WNK2 ARHGAP33	9.62e-13	486	157	19	20936779
Pubmed	Human transcription factor protein interaction networks.	NCOA6 ZNF536 ZBTB33 ACACB EP400 MAZ PROSER1 PPP6R1 POGZ UPF1 TNRC6C MLLT10 SRCAP SSBP3 CREBBP LENG8 YEATS2 NCOR1 KMT2C KANSL1 UBN1 ZFHX4 ATXN2 SS18L1 MITF NCOA1 SMARCD3 RCOR3 RERE EP300	1.82e-12	1429	157	30	35140242
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	EP400P1 ERBB2 ZNF536 ERBB4 TUT4 ZBTB33 EP400 CECR2 MAZ ADNP2 RNF213 PPP6R1 POGZ SRCAP CREBBP YEATS2 ZFHX4 SS18L1 RTL9 MACF1 SMARCD3 RCOR3 RERE EP300 ARHGAP33 KNL1	6.84e-12	1116	157	26	31753913
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NCOA6 ERBB2 ERBB4 SHROOM3 MAP4 MAZ E2F8 MEX3C ZCCHC14 VPS13D ZFP36L1 DYRK1B MACF1 UTRN ARHGAP21 PRRC1 CNOT4 EPB41 TP53BP2 CRTC2 OTOG	3.84e-10	861	157	21	36931259
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA6 ZBTB33 EP400 MAP4 NCK1 POGZ UPF1 SRCAP CREBBP CRKL YEATS2 NCOR1 KMT2C MED23 EP300 EPB41 TP53BP2	5.87e-10	549	157	17	38280479
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF536 ZBTB33 ACACB PPP6R1 POGZ CRKL YEATS2 NCOR1 ZFHX4 RCOR3 RERE UTRN ARHGAP21 TP53BP2 KNL1	8.67e-10	418	157	15	34709266
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	EP400 CECR2 MAZ ADNP2 DDI2 POGZ CREBBP YEATS2 KMT2C TNRC18 ZFHX4 DYRK1B NCOA1 EP300	4.18e-09	398	157	14	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF536 EP400 CDK19 PPP6R1 POGZ TNRC6C ZCCHC14 YEATS2 KANSL1 BTBD7 MACF1 RERE NFAT5 ARHGAP21	5.55e-09	407	157	14	12693553
Pubmed	A census of human transcription factors: function, expression and evolution.	ATF7 ZBTB33 MAZ SREBF1 ADNP2 E2F8 PGR HOXA6 YEATS2 TSC22D1 ZFHX4 ZFP36L1 ZNF335 MITF ZFHX2 NCOA1 RCOR3 PAX4 RERE NFAT5	5.85e-09	908	157	20	19274049
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 NCAPD3 EP400 MAP4 SGTA DAB2 POGZ IQCN YEATS2 NCOR1 PTPRC KANSL1 UBN1 ZNF335 FHOD1 RERE COASY BAG6	1.57e-08	774	157	18	15302935
Pubmed	Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.	NCAPD3 SSBP3 CREBBP MITF MED23 MED26 EP300	2.08e-08	66	157	7	23275444
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA6 CREBBP NCOR1 NCOA1 EP300	2.58e-08	20	157	5	11877444
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZNF536 ZBTB33 SREBF1 POGZ MLLT10 CREBBP RTN2 MEX3C PGR HOXA6 ZCCHC14 KMT2C ZFHX2 NCOA1 MACF1 PAX4 NFAT5	2.60e-08	709	157	17	22988430
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATF7 NCOA6 NCAPD3 EP400 MAP4 KNSTRN POGZ UPF1 CREBBP E2F8 LENG8 YEATS2 NCOR1 KMT2C TNRC18 ATXN2 NCOA1 MED23 BAG6 EP300 KNL1	2.93e-08	1103	157	21	34189442
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ABHD14A ERBB2 CTTNBP2 BCL2L11 OBSCN DDI2 CC2D1B HERC2P3 EML3 ZCCHC14 LENG8 COL18A1 TSC22D1 TNRC18 LRFN4 UBN1 ZFP36L1 FHOD1 KIT UTRN EP300 INS-IGF2	3.23e-08	1215	157	22	15146197
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA6 CREBBP NCOR1 NCOA1 EP300	3.38e-08	21	157	5	19596656
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA6 ZBTB33 EP400 CREBBP LENG8 NCOR1 TNRC18 NCOA1 RCOR3 RERE KNL1	4.30e-08	268	157	11	33640491
Pubmed	Composite co-activator ARC mediates chromatin-directed transcriptional activation.	SREBF1 CREBBP MED23 MED26 EP300	5.54e-08	23	157	5	10235267
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	CREBBP NCOR1 NCOA1 EP300	8.22e-08	10	157	4	30595551
Pubmed	Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein.	SRCAP CREBBP EP300	9.02e-08	3	157	3	10347196
Pubmed	CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation.	CREBBP EP300 CRTC2	9.02e-08	3	157	3	20859256
Pubmed	Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.	CREBBP SS18L1 EP300	9.02e-08	3	157	3	14716005
Pubmed	Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.	EP400 CREBBP EP300	9.02e-08	3	157	3	9590171
Pubmed	Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.	CREBBP NCOR1 NCOA1 EP300	1.29e-07	11	157	4	15681609
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	ATF7 TUT4 CTTNBP2 ABI3BP CDH23 UPF1 PLXND1 VPS13D BAG6 WNK2	1.29e-07	235	157	10	30258100
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCOA6 NCAPD3 ERBB2 SHROOM3 EP400 CECR2 POGZ PLXND1 NACAD KMT2C ARHGAP31 MAML2 MED23 WNK2	1.43e-07	529	157	14	14621295
Pubmed	Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.	NCOA6 CREBBP NCOA1 EP300	1.92e-07	12	157	4	12189208
Pubmed	Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms.	CREBBP EP300 CRTC2	3.60e-07	4	157	3	17525731
Pubmed	SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.	SREBF1 CREBBP EP300	3.60e-07	4	157	3	8918891
Pubmed	A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.	CREBBP NCOR1 NCOA1	3.60e-07	4	157	3	10339548
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	CREBBP KMT2C EP300	3.60e-07	4	157	3	28398509
Pubmed	Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR).	CREBBP NCOR1 EP300	3.60e-07	4	157	3	17073437
Pubmed	Binding and modulation of p53 by p300/CBP coactivators.	EP400 CREBBP EP300	3.60e-07	4	157	3	9194565
Pubmed	Adenovirus DNA binding protein interacts with the SNF2-related CBP activator protein (SrCap) and inhibits SrCap-mediated transcription.	SRCAP CREBBP EP300	3.60e-07	4	157	3	11581372
Pubmed	Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.	CREBBP NCOA1 EP300	3.60e-07	4	157	3	12208951
Pubmed	The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.	CREBBP NCOA1 EP300	3.60e-07	4	157	3	11463834
Pubmed	Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1.	CREBBP NCOA1 EP300	3.60e-07	4	157	3	11113179
Pubmed	An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells.	CREBBP KIT EP300	3.60e-07	4	157	3	27633918
Pubmed	Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium.	PGR NCOA1 EP300	3.60e-07	4	157	3	12574227
Pubmed	Impaired development of melanoblasts in the black-eyed white Mitf(mi-bw) mouse, a model for auditory-pigmentary disorders.	PTPRC MITF KIT	3.60e-07	4	157	3	22563733
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA6 CREBBP KMT2C NCOA1	3.86e-07	14	157	4	12482968
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN RNF213 GPAM TNRC6C MAGEE1 MSL2 KNL1	4.03e-07	101	157	7	10997877
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L CTTNBP2 RNF213 CC2D1B GPAM NPHP4 MSL2 FARP2 TSC22D1 VPS13D TNRC18 SS18L1 MACF1	4.25e-07	493	157	13	15368895
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TROAP PROSER1 TNRC6C SSBP3 CREBBP NCOA1 EP300 CNOT4	4.87e-07	152	157	8	38360978
Pubmed	Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression.	CREBBP EP300 CRTC2	8.97e-07	5	157	3	17476304
Pubmed	A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP.	CREBBP NCOA1 EP300	8.97e-07	5	157	3	14722092
Pubmed	Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.	CREBBP MED23 EP300	8.97e-07	5	157	3	15572696
Pubmed	Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.	NCOA6 CREBBP EP300	8.97e-07	5	157	3	11912212
Pubmed	Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.	ITGAX PTPRC IL2RB	8.97e-07	5	157	3	23018460
Pubmed	Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.	NCOR1 NCOA1 EP300	8.97e-07	5	157	3	14985122
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	CREBBP NCOR1 NCOA1 EP300	9.09e-07	17	157	4	19183483
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZBTB33 EP400 MAP4 UPF1 CREBBP YEATS2 NCOR1 UBN1 FHOD1 MITF MED23 MED26	9.29e-07	444	157	12	34795231
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SECISBP2L DAB2 PPP6R1 POGZ UPF1 TNRC6C FCHO2 MEX3C FARP2 RABL6 ZFP36L1 BTBD7 MITF AGFG2 MAPK7 ARHGAP21 CNOT4 CRTC2	1.18e-06	1038	157	18	26673895
Pubmed	Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.	ERBB2 ERBB4 NCK1 CRKL SLA2 TNS1	1.40e-06	77	157	6	22973453
Pubmed	Phosphotyrosine interactome of the ErbB-receptor kinase family.	ERBB2 ERBB4 NCK1 CRKL	1.47e-06	19	157	4	16729043
Pubmed	An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.	SREBF1 CREBBP MED23 MED26	1.47e-06	19	157	4	16799563
Pubmed	Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.	CREBBP MAML2 EP300	1.79e-06	6	157	3	15961999
Pubmed	Temporal/spatial expression of nuclear receptor coactivators in the mouse lung.	CREBBP NCOA1 EP300	1.79e-06	6	157	3	11076796
Pubmed	Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation.	CREBBP NCOA1 EP300	1.79e-06	6	157	3	10497212
Pubmed	The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.	NCOR1 NCOA1 EP300	1.79e-06	6	157	3	17468099
Pubmed	Role of CBP in regulating HIF-1-mediated activation of transcription.	CREBBP NCOA1 EP300	1.79e-06	6	157	3	15615775
Pubmed	DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells.	CREBBP NCOA1 EP300	1.79e-06	6	157	3	10973497
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 ZNF536 EP400 POGZ NCOR1 EP300	2.18e-06	83	157	6	28794006
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	EP400 PLXND1 SSPOP VPS13D MACF1 MED23 NFAT5	2.22e-06	130	157	7	12421765
Pubmed	Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.	NCOA6 SREBF1 GPAM CREBBP NCOR1 NCOA1 MED23 EP300 ARHGAP33	2.23e-06	250	157	9	18660489
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	NCAPD3 ZBTB33 EP400 MAP4 DAB2 RNF213 UPF1 SRCAP EML3 NCOR1	2.98e-06	332	157	10	32786267
Pubmed	CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.	ITGAX PTPRC IL2RB	3.12e-06	7	157	3	17923507
Pubmed	Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.	CREBBP PGR EP300	3.12e-06	7	157	3	12101239
Pubmed	Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.	ERBB2 NCOR1 NCOA1	3.12e-06	7	157	3	15788656
Pubmed	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	CREBBP NCOA1 EP300	3.12e-06	7	157	3	9590696
Pubmed	Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression.	CREBBP NCOR1 EP300	4.97e-06	8	157	3	20935208
Pubmed	Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.	NCOA6 MED23 EP300	4.97e-06	8	157	3	10823961
Pubmed	Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression.	CREBBP NCOA1 EP300	4.97e-06	8	157	3	17475621
Pubmed	The basic helix-loop-helix proteins differentiated embryo chondrocyte (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.	SREBF1 NCOR1 NCOA1	4.97e-06	8	157	3	19786558
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZBTB33 ACACB EP400 MAP4 PPP6R1 UPF1 SRCAP LENG8 YEATS2 FHOD1 MACF1 UTRN ARHGAP21 EPB41 TP53BP2 KNL1	5.59e-06	934	157	16	33916271
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CTTNBP2 CECR2 IQCN ZFHX2 TMEM108 WNK2	7.24e-06	102	157	6	11214970
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 EP400 SRCAP CREBBP SS18L1 SMARCD3 EP300	7.72e-06	157	157	7	30186101
Pubmed	Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45.	NCK1 CRKL PTPRC	1.06e-05	10	157	3	16503409
Pubmed	Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.	NCOR1 NCOA1 EP300	1.06e-05	10	157	3	12738788
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	NCOA6 EP400 DAB2 FCHO2 YEATS2 FHOD1 MACF1 ARHGAP21 EPB41 TP53BP2 KNL1	1.08e-05	472	157	11	38943005
Pubmed	Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation.	CREBBP NCOA1 EP300	1.45e-05	11	157	3	10454579
Pubmed	Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.	ERBB2 ERBB4 NRP1	1.45e-05	11	157	3	25315821
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	ZNF536 EP400 ADNP2 YEATS2 BAG6 KNL1	1.52e-05	116	157	6	30804394
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	NCOA6 TROAP ADNP2 POGZ YEATS2 KMT2C KANSL1 DYRK1B RCOR3 RERE KNL1	1.68e-05	495	157	11	27705803
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ATF7 ZBTB33 SREBF1 ZDHHC14 POGZ MLLT10 SRCAP ZCCHC14 NCOR1 TSC22D1 ZFP36L1 BTBD7 NCOA1 NFAT5	1.95e-05	808	157	14	20412781
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	2.02e-05	2	157	2	27881875
Pubmed	Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.	MITF KIT	2.02e-05	2	157	2	7524330
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	2.02e-05	2	157	2	34845315
Pubmed	KITD816V Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma.	MITF KIT	2.02e-05	2	157	2	28584020
Pubmed	Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.	ERBB2 ERBB4	2.02e-05	2	157	2	20022944
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	2.02e-05	2	157	2	20717166
Pubmed	Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.	ERBB2 PGR	2.02e-05	2	157	2	26579819
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	2.02e-05	2	157	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	2.02e-05	2	157	2	11559821
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	2.02e-05	2	157	2	19822209
Pubmed	Characterization of EGFR family gene aberrations in cholangiocarcinoma.	ERBB2 ERBB4	2.02e-05	2	157	2	24927194
Interaction	EGR2 interactions	NCOA6 ZNF536 EP400 PROSER1 POGZ CREBBP NCOR1 KMT2C TNRC18 ZFHX4 SS18L1 MITF NCOA1 SMARCD3 RERE EP300	3.05e-13	171	155	16	int:EGR2
Interaction	SP7 interactions	NCOA6 ZNF536 EP400 PROSER1 POGZ SSBP3 CREBBP LENG8 NCOR1 KMT2C ZFHX4 SS18L1 MITF NCOA1 SMARCD3 RCOR3 RERE EP300	2.30e-11	304	155	18	int:SP7
Interaction	HNF4A interactions	NCOA6 EP400 SREBF1 POGZ SRCAP CREBBP YEATS2 NCOR1 KMT2C KANSL1 UBN1 SS18L1 NCOA1 SMARCD3 RCOR3 MED23 EP300	4.34e-11	275	155	17	int:HNF4A
Interaction	TBXT interactions	NCOA6 ZNF536 POGZ SSBP3 CREBBP NCOR1 KMT2C ZFHX4 SS18L1 RCOR3 EP300	1.53e-09	116	155	11	int:TBXT
Interaction	FOS interactions	ATF7 NCOA6 ACACB EP400 MAZ CREBBP NCOR1 KMT2C UBN1 SS18L1 MITF NCOA1 SMARCD3 MAPK7 NFAT5 EP300	2.55e-09	312	155	16	int:FOS
Interaction	HNF1B interactions	ZNF536 EP400 PROSER1 POGZ MLLT10 CREBBP NCOR1 KMT2C UBN1 ZFHX4 SMARCD3 EP300	2.79e-08	190	155	12	int:HNF1B
Interaction	ETS1 interactions	EP400 SRCAP CREBBP NCOR1 SS18L1 NCOA1 SMARCD3 MAPK7 MED23 EP300	3.30e-08	121	155	10	int:ETS1
Interaction	FEV interactions	NCOA6 EP400 POGZ MLLT10 SSBP3 CREBBP LENG8 NCOR1 KMT2C ZFHX4 SS18L1 EP300	5.80e-08	203	155	12	int:FEV
Interaction	TOP3B interactions	HEXA NCOA6 ERBB2 SHROOM3 BCL2L11 EP400 OBSCN SREBF1 PPP6R1 UPF1 PLXND1 TNRC6C MLLT10 SRCAP NPHP4 EML3 CRKL RABL6 ZCCHC14 NCOR1 KMT2C TNRC18 KANSL1 UBN1 ATXN2 BTBD7 ZNF335 ARHGAP21 EP300 WNK2 ARHGAP33 RAB11FIP3	6.70e-08	1470	155	32	int:TOP3B
Interaction	CRX interactions	ZNF536 EP400 PROSER1 POGZ CREBBP KMT2C TNRC18 ZFHX4 SS18L1 NCOA1 SMARCD3 RERE EP300	8.70e-08	254	155	13	int:CRX
Interaction	TEAD1 interactions	ZNF536 MAZ SSBP3 CREBBP NCOR1 KMT2C ZFHX4 NCOA1 SMARCD3 RCOR3 EP300	1.20e-07	176	155	11	int:TEAD1
Interaction	TLE3 interactions	CECR2 PROSER1 MLLT10 CREBBP NCOR1 TNRC18 AGFG2 NCOA1 SAGE1 RERE MED23 EP300 CNOT4 CRTC2 KNL1	2.23e-07	376	155	15	int:TLE3
Interaction	SOX7 interactions	CECR2 ADNP2 CREBBP KMT2C TNRC18 ZFHX4 NCOA1 EP300	2.25e-07	82	155	8	int:SOX7
Interaction	PAX7 interactions	SSBP3 CREBBP NCOR1 KMT2C ZFHX4 SS18L1 SMARCD3 RCOR3 EP300	4.98e-07	124	155	9	int:PAX7
Interaction	PAX6 interactions	NCOA6 ZNF536 EP400 POGZ SRCAP CREBBP NCOR1 KMT2C ZFHX4 SS18L1 MITF SMARCD3 RCOR3 EP300	9.49e-07	366	155	14	int:PAX6
Interaction	ERG interactions	NCOA6 MLLT10 CREBBP NCOR1 KMT2C ZFHX4 SS18L1 MITF SMARCD3 RERE EP300	1.28e-06	223	155	11	int:ERG
Interaction	PAX8 interactions	PROSER1 SSBP3 CREBBP NCOR1 KMT2C ZFHX4 SS18L1 EP300	2.31e-06	111	155	8	int:PAX8
Interaction	KLF5 interactions	NCOA6 EP400 MAZ SREBF1 MLLT10 CREBBP LENG8 NCOR1 KMT2C EP300	2.78e-06	195	155	10	int:KLF5
Interaction	NR1H4 interactions	NCOA6 NCOR1 NCOA1 SMARCD3 EP300	4.30e-06	32	155	5	int:NR1H4
Interaction	GSC interactions	ZNF536 CREBBP KMT2C TNRC18 ZFHX4 RERE EP300	4.85e-06	87	155	7	int:GSC
Interaction	NR1H3 interactions	NCOA6 DDI2 NCOR1 SS18L1 NCOA1 EP300	5.47e-06	58	155	6	int:NR1H3
Interaction	SMG7 interactions	SECISBP2L NCOA6 UPF1 TNRC6C MLLT10 CREBBP LENG8 YEATS2 NCOR1 ATXN2 NCOA1 RCOR3	6.93e-06	319	155	12	int:SMG7
Interaction	FOXI1 interactions	ZNF536 MLLT10 CREBBP KMT2C ZFHX4 RCOR3 EP300	7.04e-06	92	155	7	int:FOXI1
Interaction	TLX1 interactions	ZNF536 POGZ SSBP3 CREBBP NCOR1 KMT2C ZFHX4 RCOR3 EP300	8.67e-06	175	155	9	int:TLX1
Interaction	MYB interactions	ZNF536 ZBTB33 POGZ UPF1 CREBBP NCOR1 KANSL1 EP300	8.88e-06	133	155	8	int:MYB
Interaction	YWHAH interactions	NCOA6 SHROOM3 MAZ CREBBP EML3 E2F8 MEX3C ZCCHC14 VPS13D ZFP36L1 MITF NCOA1 MACF1 MAPK7 UTRN ARHGAP21 PRRC1 CNOT4 EPB41 WNK2 TP53BP2 CRTC2 OTOG	1.22e-05	1102	155	23	int:YWHAH
Interaction	SMARCA4 interactions	EP400 CDK19 SREBF1 UPF1 SRCAP SSBP3 CREBBP RABL6 NCOR1 UBN1 SS18L1 NCOA1 SMARCD3 EP300	1.39e-05	462	155	14	int:SMARCA4
Interaction	GCM1 interactions	ZNF536 CREBBP NCOR1 KMT2C RCOR3 EP300	1.39e-05	68	155	6	int:GCM1
Interaction	PHF21A interactions	ZNF536 ZBTB33 ACACB PPP6R1 CRKL YEATS2 ZFHX4 RCOR3 UTRN ARHGAP21 TP53BP2 KNL1	1.43e-05	343	155	12	int:PHF21A
Interaction	TNS1 interactions	ERBB2 ERBB4 KIT TNS1 UTRN	1.51e-05	41	155	5	int:TNS1
Interaction	NCOA6 interactions	NCOA6 CREBBP KMT2C ZNF335 FHOD1 NCOA1 MED23 EP300	1.67e-05	145	155	8	int:NCOA6
Interaction	ABL2 interactions	ERBB2 ERBB4 NCK1 SSTR3 CRKL TNRC18 KIT	1.90e-05	107	155	7	int:ABL2
Interaction	EYA4 interactions	TROAP DDI2 PROSER1 TNRC6C SSBP3 CREBBP CRKL NCOA1 EP300 CNOT4	1.92e-05	243	155	10	int:EYA4
Interaction	ASF1A interactions	NCOA6 ZNF536 EP400 POGZ SRCAP LENG8 YEATS2 NCOR1 UBN1 EP300	2.37e-05	249	155	10	int:ASF1A
Interaction	GATA2 interactions	NCOA6 ZNF536 SSBP3 CREBBP NCOR1 KMT2C ZFHX4 RCOR3 EP300	2.42e-05	199	155	9	int:GATA2
Interaction	GUSBP5 interactions	TROAP ZCCHC14 NCOR1 TNRC18 ZFHX4 ATXN2	2.44e-05	75	155	6	int:GUSBP5
Interaction	TBR1 interactions	ZNF536 PROSER1 SSBP3 NCOR1 KMT2C ZFHX4 EP300	2.71e-05	113	155	7	int:TBR1
Interaction	RCOR1 interactions	ZNF536 ZBTB33 ACACB PPP6R1 CRKL YEATS2 NCOR1 ZFHX4 RCOR3 MED23 UTRN ARHGAP21 TP53BP2 KNL1	2.91e-05	494	155	14	int:RCOR1
Interaction	SLA2 interactions	ERBB2 ERBB4 SLA2 KIT	3.17e-05	24	155	4	int:SLA2
Interaction	NR6A1 interactions	CREBBP NCOR1 NCOA1 EP300	3.17e-05	24	155	4	int:NR6A1
Interaction	NR1I2 interactions	NCOA6 NCOR1 NCOA1 MAPK7 EP300	3.31e-05	48	155	5	int:NR1I2
Interaction	DYNLL2 interactions	SECISBP2L NCOA6 CTTNBP2 BCL2L11 KNSTRN POGZ EML3 KMT2C LRFN4 RCOR3	3.77e-05	263	155	10	int:DYNLL2
Interaction	MED23 interactions	NCOA6 EP400 CDK19 SREBF1 CREBBP DYRK1B MED23 MED26 BAG6 EP300	4.15e-05	266	155	10	int:MED23
Interaction	RXRA interactions	NCOA6 CREBBP NCOR1 NCOA1 SMARCD3 MAPK7 MED23 EP300	5.01e-05	169	155	8	int:RXRA
Interaction	SETD1A interactions	NCOA6 CREBBP YEATS2 KMT2C KANSL1 SMARCD3 RERE EP300	5.22e-05	170	155	8	int:SETD1A
Interaction	FHL2 interactions	ADAMTSL1 EP400 POGZ CREBBP YEATS2 NCOR1 TNRC18 MITF RCOR3 NFAT5 EP300 KNL1	5.83e-05	396	155	12	int:FHL2
Interaction	ELF3 interactions	ERBB2 CECR2 CREBBP MED23 EP300	5.89e-05	54	155	5	int:ELF3
Interaction	IRF5 interactions	SGTA PPP6R1 CREBBP NCOR1 EP300	5.89e-05	54	155	5	int:IRF5
Interaction	CIITA interactions	EP400 SSBP3 CREBBP NCOA1 EP300	6.44e-05	55	155	5	int:CIITA
Interaction	PAX9 interactions	NCOA6 ZNF536 PROSER1 NCOR1 KMT2C ZFHX4 EP300	6.66e-05	130	155	7	int:PAX9
Interaction	EP300 interactions	NCOA6 ZBTB33 MAP4 MAZ SREBF1 UPF1 SRCAP CREBBP PGR RABL6 NCOR1 THPO UBN1 SS18L1 DYRK1B MITF NCOA1 MAML2 RERE MED23 BAG6 EP300 CNOT4 TP53BP2 CRTC2	6.72e-05	1401	155	25	int:EP300
Interaction	STAT5A interactions	ERBB4 CRKL PGR NCOA1 KIT IL2RB EP300	6.99e-05	131	155	7	int:STAT5A
Interaction	YWHAZ interactions	HEXA NCAPD3 ERBB2 SHROOM3 ZBTB33 SGK1 EML3 E2F8 MSL2 NCOR1 VPS13D ZFP36L1 FHOD1 MACF1 MAPK7 TNS1 ARHGAP21 EP300 EPB41 WNK2 TP53BP2 CRTC2 OTOG IL9R	7.08e-05	1319	155	24	int:YWHAZ
Interaction	DYRK1B interactions	EP400 TROAP CREBBP DYRK1B MED23 EP300	7.31e-05	91	155	6	int:DYRK1B
Interaction	ZAP70 interactions	ERBB2 ERBB4 CRKL PTPRC SLA2 KIT	7.77e-05	92	155	6	int:ZAP70
Interaction	RBBP5 interactions	NCOA6 ACACB CREBBP YEATS2 KMT2C KANSL1 ZNF335 RERE MED23 EP300	7.84e-05	287	155	10	int:RBBP5
Interaction	TLX3 interactions	NCOA6 PROSER1 POGZ SSBP3 NCOR1 KMT2C ZFHX4 RCOR3 RERE EP300	8.79e-05	291	155	10	int:TLX3
Interaction	PIAS3 interactions	ERBB4 CREBBP PGR MITF ARHGAP21 EP300	9.29e-05	95	155	6	int:PIAS3
Interaction	LHX3 interactions	POGZ SSBP3 CREBBP NCOR1 KMT2C ZFHX4 SS18L1 RCOR3	9.46e-05	185	155	8	int:LHX3
Interaction	ATN1 interactions	SSPOP LENG8 YEATS2 KMT2C KANSL1 SS18L1 RERE BAG6	1.02e-04	187	155	8	int:ATN1
Interaction	WWTR1 interactions	NCOA6 ZBTB33 EP400 POGZ SRCAP CREBBP CRKL YEATS2 NCOR1 EP300 EPB41 TP53BP2	1.07e-04	422	155	12	int:WWTR1
Interaction	NCOA2 interactions	NCOA6 SRCAP CREBBP PGR NCOA1 MED23 EP300	1.11e-04	141	155	7	int:NCOA2
Interaction	KDM1A interactions	ZBTB33 ACACB EP400 PPP6R1 POGZ CRKL LENG8 YEATS2 NCOR1 KANSL1 ZFHX4 RCOR3 RERE MED23 UTRN ARHGAP21 EP300 TP53BP2 KNL1	1.15e-04	941	155	19	int:KDM1A
Interaction	CXCL8 interactions	ERBB2 SGTA BAG6 EP300	1.16e-04	33	155	4	int:CXCL8
Interaction	ASCL2 interactions	NCOA6 KMT2C EP300	1.21e-04	13	155	3	int:ASCL2
Interaction	SMARCB1 interactions	BCL2L11 MLLT10 SRCAP CREBBP LENG8 NCOR1 KMT2C UBN1 SS18L1 SMARCD3 EP300	1.22e-04	364	155	11	int:SMARCB1
Interaction	TRRAP interactions	HEXA SHROOM3 TUT4 EP400 SREBF1 NCK1 UPF1 SRCAP CREBBP YEATS2 NCOR1 LRFN4 DYRK1B SMARCD3 MED23 MED26 ARHGAP21	1.27e-04	790	155	17	int:TRRAP
Interaction	MYOD1 interactions	EP400 CREBBP NCOR1 KMT2C SS18L1 NCOA1 SMARCD3 EP300	1.31e-04	194	155	8	int:MYOD1
Interaction	FBXO38 interactions	ZNF536 EP400 ADNP2 CREBBP YEATS2 BAG6 KNL1	1.32e-04	145	155	7	int:FBXO38
Interaction	SKAP1 interactions	NCAPD3 CC2D1B NPHP4 EML3 PTPRC ATXN2	1.38e-04	102	155	6	int:SKAP1
Interaction	TSC22D3 interactions	SGK1 DAB2 IQCN HOXA6 TSC22D1	1.66e-04	67	155	5	int:TSC22D3
Interaction	SPDL1 interactions	ATF7 TUT4 CTTNBP2 ABI3BP CDH23 UPF1 PLXND1 VPS13D BAG6 WNK2	1.68e-04	315	155	10	int:SPDL1
Interaction	NR1H2 interactions	NCOA6 ACVRL1 NCOR1 NCOA1 BAG6	1.78e-04	68	155	5	int:NR1H2
Interaction	SUMO2 interactions	NCAPD3 ZBTB33 EP400 MAP4 DAB2 RNF213 POGZ UPF1 SRCAP EML3 NCOR1 RCOR3 EP300 TP53BP2	1.95e-04	591	155	14	int:SUMO2
Interaction	EN1 interactions	ZNF536 EP400 NCOR1 KMT2C ZFHX4 EP300	2.08e-04	110	155	6	int:EN1
Interaction	CEBPA interactions	ATF7 NCOA6 NCAPD3 EP400 MAP4 KNSTRN POGZ UPF1 CREBBP E2F8 LENG8 YEATS2 NCOR1 KMT2C TNRC18 ATXN2 NCOA1 MACF1 MED23 BAG6 EP300 KNL1	2.21e-04	1245	155	22	int:CEBPA
Interaction	CREBBP interactions	HEXA NCOA6 SREBF1 SRCAP CREBBP NCOR1 SS18L1 DYRK1B MITF NCOA1 MAML2 MED23 EP300 TP53BP2	2.23e-04	599	155	14	int:CREBBP
Interaction	RORA interactions	CREBBP NCOA1 SMARCD3 EP300	2.25e-04	39	155	4	int:RORA
Interaction	AR interactions	NCOA6 ZBTB33 EP400 SREBF1 RNF213 SRCAP CREBBP LENG8 NCOR1 KMT2C TNRC18 NCOA1 RCOR3 RERE MED23 TNS1 BAG6 EP300 KNL1	2.27e-04	992	155	19	int:AR
Interaction	YWHAG interactions	NCOA6 SHROOM3 ZBTB33 MAZ EML3 E2F8 MSL2 FARP2 VPS13D LRFN4 ZFP36L1 MITF MACF1 MAPK7 UTRN ARHGAP21 PRRC1 CNOT4 EPB41 TP53BP2 CRTC2 OTOG	2.29e-04	1248	155	22	int:YWHAG
Interaction	FBLN5 interactions	SECISBP2L ATF7 ZBTB33 TROAP IQCN UTRN ARHGAP21	2.34e-04	159	155	7	int:FBLN5
Interaction	CISH interactions	ERBB2 BCL2L11 KIT IL2RB	2.48e-04	40	155	4	int:CISH
Interaction	KDM6A interactions	NCOA6 PROSER1 CREBBP YEATS2 KMT2C KANSL1 RERE	2.62e-04	162	155	7	int:KDM6A
Interaction	ZAR1L interactions	SECISBP2L BCL2L11 EML3	2.80e-04	17	155	3	int:ZAR1L
Interaction	MAML2 interactions	CREBBP MAML2 EP300	2.80e-04	17	155	3	int:MAML2
Interaction	SETD1B interactions	NCOA6 YEATS2 KMT2C KANSL1 RERE	2.82e-04	75	155	5	int:SETD1B
Interaction	YAP1 interactions	NCOA6 ERBB4 ZBTB33 MAP4 NCK1 POGZ UPF1 SRCAP CREBBP CRKL NCOR1 COL18A1 KMT2C TNRC18 MED23 NFAT5 EP300 CNOT4 EPB41 TP53BP2	2.86e-04	1095	155	20	int:YAP1
Interaction	JUN interactions	ATF7 NCOA6 MAZ CREBBP NCOR1 KMT2C UBN1 NCOA1 MACF1 SMARCD3 NFAT5 EP300	2.88e-04	470	155	12	int:JUN
Interaction	JDP2 interactions	ATF7 CREBBP PGR EP300	3.00e-04	42	155	4	int:JDP2
Interaction	CDK8 interactions	ERBB2 CDK19 SREBF1 CREBBP YEATS2 MED23 MED26 BAG6	3.29e-04	222	155	8	int:CDK8
Interaction	MEX3B interactions	TUT4 UPF1 TNRC6C ACVRL1 MEX3C ZCCHC14 ATXN2 CNOT4	3.29e-04	222	155	8	int:MEX3B
Interaction	HDAC1 interactions	ZNF536 ZBTB33 ACACB EP400 SREBF1 GPAM PPP6R1 CREBBP CRKL YEATS2 NCOR1 TNRC18 ZFHX4 RCOR3 RERE UTRN ARHGAP21 EP300 TP53BP2 KNL1	3.33e-04	1108	155	20	int:HDAC1
Interaction	DUXB interactions	ACACB POGZ ZFHX4	3.35e-04	18	155	3	int:DUXB
Interaction	HNF1A interactions	POGZ CREBBP KMT2C NCOA1 EP300	3.81e-04	80	155	5	int:HNF1A
Interaction	NFIX interactions	ZNF536 EP400 POGZ SRCAP NCOR1 KMT2C ZFHX4 SMARCD3	3.81e-04	227	155	8	int:NFIX
Interaction	EPAS1 interactions	NCAPD3 SSBP3 CREBBP MITF MED23 MED26 EP300	3.90e-04	173	155	7	int:EPAS1
Interaction	SH2D1A interactions	ERBB2 ERBB4 NCK1 KIT	3.92e-04	45	155	4	int:SH2D1A
Interaction	FOXO3 interactions	BCL2L11 SGK1 DAB2 FCHO2 CREBBP EP300	3.98e-04	124	155	6	int:FOXO3
Interaction	STAT5B interactions	ERBB4 CRKL PGR KIT IL2RB EP300	4.15e-04	125	155	6	int:STAT5B
Interaction	KIT interactions	NCK1 SSTR3 CRKL SLA2 KIT TNS1	4.15e-04	125	155	6	int:KIT
Cytoband	22q11.2	CECR2 IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40	6.09e-05	120	157	5	22q11.2
Cytoband	10p12	MLLT10 NRP1	2.41e-04	7	157	2	10p12
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	CECR2 CRKL IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40 PIWIL3	6.33e-04	419	157	7	chr22q11
GeneFamily	Ataxins\|Trinucleotide repeat containing	EP400 TNRC6C TNRC18 ATXN2	1.49e-05	25	110	4	775
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ADNP2 ZFHX4 ZFHX2	9.45e-05	15	110	3	529
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP NCOA1 EP300	1.40e-04	17	110	3	486
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP UTRN EP300	1.67e-04	18	110	3	91
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 ERBB4	2.18e-04	4	110	2	1096
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 NCOR1 RCOR3 RERE	3.02e-04	53	110	4	532
GeneFamily	CD molecules\|Inhibitory leukocyte immunoglobulin like receptors	LILRB2 LILRB1	3.62e-04	5	110	2	1182
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ERBB2 LILRB2 ITGAX LILRB1 NRP1 PTPRC KIT IL2RB IL9R	6.77e-04	394	110	9	471
GeneFamily	Cyclins\|Mediator complex	CDK19 MED23 MED26	1.05e-03	33	110	3	1061
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV1-50 IGLV1-47 IGLV1-44 IGLV1-40	2.13e-03	89	110	4	353
GeneFamily	SH2 domain containing	NCK1 CRKL SLA2 TNS1	3.37e-03	101	110	4	741
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP31 ARHGAP21 ARHGAP33	3.49e-03	50	110	3	721
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	NCOR1 UBN1 TNS1 TP53BP2 KNL1	5.00e-03	181	110	5	694
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TUT4 CREBBP YEATS2 NCOR1 KMT2C KANSL1 TMEM245 DYRK1B MACF1 NFAT5 UTRN EP300	9.06e-10	180	156	12	M8239
Coexpression	GSE45837_WT_VS_GFI1_KO_PDC_UP	ARPP21 DAB2 PROSER1 MSL2 RABL6 SAGE1 UTRN EP300 ARHGAP33	2.70e-06	195	156	9	M9892
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	TUT4 CREBBP MSL2 TSC22D1 PTPRC UBN1 ZFP36L1 MACF1 EPB41	3.19e-06	199	156	9	M7596
Coexpression	GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	CTTNBP2 RNF213 CREBBP EML3 NCOR1 PTPRC RERE NFAT5 UTRN	3.32e-06	200	156	9	M5063
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	ACACB TROAP TNRC6C FCHO2 NCOR1 MACF1 NFAT5 CRTC2	7.16e-06	166	156	8	M6826
Coexpression	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	SECISBP2L TNRC6C NCOR1 KMT2C TSC22D1 MITF NCOA1 KIT	1.29e-05	180	156	8	M8906
Coexpression	GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	PROSER1 POGZ PTGIR TSC22D1 LRFN4 ATXN2 MED23 KIT	2.57e-05	198	156	8	M9163
Coexpression	GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP	TUT4 ZDHHC14 RNF213 ACVRL1 PTGIR UBN1 TMEM108 TNS1	2.66e-05	199	156	8	M9269
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	SECISBP2L ABHD14A ERBB2 ACACB SGK1 RNF213 POGZ NCOR1 TSC22D1 KANSL1 ATXN2 LTBP2 RERE MED23 TNS1 EPB41	2.70e-05	807	156	16	M16651
Coexpression	GSE27786_CD4_VS_CD8_TCELL_UP	SECISBP2L DDI2 SRCAP SSBP3 CREBBP MSL2 TSC22D1 ARHGAP31	2.76e-05	200	156	8	M4819
Coexpression	GSE31082_DN_VS_DP_THYMOCYTE_DN	SECISBP2L SGK1 TNRC6C MLLT10 PTPRC MAPK7 NFAT5 EP300	2.76e-05	200	156	8	M5055
Coexpression	GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	TUT4 BCL2L11 TNRC6C MAGEE1 KMT2C VPS13D RCOR3 UTRN	2.76e-05	200	156	8	M8954
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	ABHD14A DAB2 ZDHHC14 NRP1 VPS13D BTBD7 TMEM245 ARHGAP21	2.76e-05	200	156	8	M7978
Coexpression	CHANDRAN_METASTASIS_UP	EP400 KMT2C KANSL1 ZFP36L1 ATXN2 PRRC1 EPB41 CRB2	3.78e-05	209	156	8	M16036
Coexpression	STK33_NOMO_UP	SGK1 DAB2 CC2D1B FCHO2 NRP1 RABL6 ZCCHC14 ZFP36L1 BTBD7	6.33e-05	290	156	9	M2855
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	SHROOM3 RNF213 NRP1 COL18A1 KANSL1 MAML2 RERE	9.18e-05	176	156	7	M39223
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	SECISBP2L NCOA6 CDK19 ADNP2 CREBBP RTN2 ZCCHC14 TSC22D1 NCOA1 MAPK7 NFAT5 EP300 PRRC1 CNOT4 TP53BP2	1.23e-04	822	156	15	M6782
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	DDI2 FCHO2 ZCCHC14 TSC22D1 VPS13D NFAT5 RAB11FIP3	1.43e-04	189	156	7	M8275
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	ERBB2 RNF213 MLLT10 CREBBP SS18L1 MAML2 KIT EP300 KNL1	1.43e-04	323	156	9	M9150
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	TUT4 BCL2L11 SREBF1 POGZ FCHO2 SSBP3 KMT2C TSC22D1 ZFP36L1 BTBD7 ZNF335 MITF LTBP2 MAML2 ARHGAP21	1.61e-04	843	156	15	M2356
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	SHROOM3 CTTNBP2 ZDHHC14 MACF1 UTRN	1.65e-04	86	156	5	M39248
Coexpression	GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP	NCAPD3 SYN3 ITGAX ZCCHC14 UBN1 EPB41 TP53BP2	1.79e-04	196	156	7	M5252
Coexpression	GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	MAZ CDK19 ADNP2 MACF1 RCOR3 KIT CNOT4	1.84e-04	197	156	7	M8980
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	ACACB SGTA IQCN MLLT10 MAGEE1 KMT2C TSC22D1	1.90e-04	198	156	7	M8624
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	NCOA6 PLXND1 TNRC18 ARHGAP31 ZNF335 NFAT5 IL9R	1.90e-04	198	156	7	M6511
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	TUT4 CREBBP MSL2 TSC22D1 ZFP36L1 MACF1 EPB41	1.96e-04	199	156	7	M7607
Coexpression	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	SGK1 LILRB2 DAB2 PLXND1 NRP1 TSC22D1 TNS1	2.02e-04	200	156	7	M4624
Coexpression	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	NCOA6 LILRB2 LILRB1 NCOR1 TNRC18 FHOD1 RCOR3	2.02e-04	200	156	7	M5851
Coexpression	GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN	MAZ SREBF1 MAGEE1 ITGAX LENG8 YEATS2 ZFP36L1	2.02e-04	200	156	7	M8574
Coexpression	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	HEXA SGK1 ZDHHC14 SSBP3 TNRC18 AGFG2 RAB11FIP3	2.02e-04	200	156	7	M9847
Coexpression	GSE17721_POLYIC_VS_CPG_1H_BMDC_DN	SYN3 BCL2L11 NCK1 MLLT10 EML3 TSC22D1 SMARCD3	2.02e-04	200	156	7	M3936
Coexpression	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	SYN3 SRCAP MSL2 KMT2C UMODL1 TNS1 TP53BP2	2.02e-04	200	156	7	M7500
Coexpression	GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	SECISBP2L TUT4 CREBBP PTPRC RERE MAPK7 NFAT5	2.02e-04	200	156	7	M5059
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TUT4 EP400 RNF213 PPP6R1 TNRC6C CREBBP EML3 NCOR1 KMT2C PTPRC KANSL1 ZFP36L1 FHOD1 NCOA1 MACF1 SLA2 NFAT5 KIT IL2RB UTRN EP300	2.15e-04	1492	156	21	M40023
Coexpression	GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN	NCAPD3 ARPP21 FCHO2 NPHP4 UMODL1 DYRK1B	2.47e-04	146	156	6	M392
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	ERBB4 SHROOM3 KANSL1 MITF NCOA1 MAML2 RERE	2.57e-04	208	156	7	M39233
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	ADAMTSL1 BCL2L11 ABI3BP MAP4 DDI2 SRCAP SSBP3 CREBBP ZCCHC14 KMT2C TNRC18 KANSL1 ATXN2 ARHGAP31 AGFG2 RCOR3 LTBP2 TNS1 UTRN CNOT4 KNL1	3.40e-07	799	154	21	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP CREBBP CRKL ZCCHC14 TNRC18 KANSL1 ATXN2 UTRN KNL1	4.35e-07	259	154	12	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	BCL2L11 MAP4 DDI2 SRCAP CREBBP TNRC18 KANSL1 ATXN2 UTRN	2.89e-06	162	154	9	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	CTTNBP2 BCL2L11 MAP4 DDI2 SRCAP SSBP3 CREBBP KANSL1 UTRN CNOT4	3.22e-06	210	154	10	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	TUT4 BCL2L11 MAP4 DAB2 DDI2 SRCAP SSBP3 CREBBP CRKL ZCCHC14 KMT2C TNRC18 KANSL1 ATXN2 ARHGAP31 NFAT5 TNS1 UTRN CNOT4	5.75e-06	801	154	19	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP CREBBP ZCCHC14 TNRC18 KANSL1 ATXN2 ARHGAP31 UTRN	6.76e-06	281	154	11	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP SSBP3 CREBBP KANSL1 ATXN2 UTRN CNOT4	7.20e-06	230	154	10	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	NCAPD3 BCL2L11 MAP4 DDI2 SRCAP CREBBP TNRC18 KANSL1 ATXN2 UTRN	1.44e-05	249	154	10	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP CREBBP KMT2C KANSL1 ATXN2 UTRN CNOT4	3.37e-05	275	154	10	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	BCL2L11 MAP4 DDI2 SRCAP SSBP3 CREBBP TNRC18 KANSL1 ATXN2 TNS1 UTRN CNOT4	4.23e-05	406	154	12	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	BCL2L11 MAP4 DDI2 SRCAP SSBP3 CREBBP TNRC18 KANSL1 ATXN2 TNS1 UTRN CNOT4	4.99e-05	413	154	12	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP SSBP3 CREBBP KMT2C VPS13D TNRC18 KANSL1 ATXN2 ARHGAP31 NFAT5 TNS1 UTRN CNOT4 KNL1	6.25e-05	790	154	17	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	BCL2L11 MAP4 RNF213 DDI2 SRCAP SSBP3 CREBBP CRKL ZCCHC14 TNRC18 KANSL1 ATXN2 AGFG2 TNS1 UTRN CNOT4 KNL1	7.98e-05	806	154	17	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500	DDI2 SRCAP CREBBP KANSL1 ATXN2 CNOT4	1.31e-04	107	154	6	gudmap_developingGonad_e14.5_ epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	CTTNBP2 BCL2L11 ABI3BP MAP4 RNF213 DDI2 SRCAP SSBP3 CREBBP KMT2C KANSL1 UBN1 NFAT5 KIT UTRN CNOT4	1.74e-04	778	154	16	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	BCL2L11 MAP4 DDI2 SRCAP TNRC18 KANSL1 ATXN2 ARHGAP31 UTRN	2.36e-04	284	154	9	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3	ARPP21 MAZ SSBP3 PTGIR E2F8 YEATS2 SLA2 KIT IL2RB UTRN KNL1	2.71e-04	423	154	11	GSM476655_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	ITGAX E2F8 NRP1 IL2RB KNL1	3.46e-04	83	154	5	GSM538387_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3	TUT4 SGK1 ITGAX NRP1 ZFHX2 MACF1 SLA2 MAML2 IL2RB UTRN	3.73e-04	369	154	10	GSM605891_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	ARPP21 CECR2 GPAM SIGLEC10 KNL1	3.87e-04	85	154	5	GSM399450_100
CoexpressionAtlas	alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3	BCL2L11 PPP6R1 PLXND1 SSBP3 SLA2 MAML2 IL2RB TNS1 UTRN	3.97e-04	305	154	9	GSM399394_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3	TUT4 SGK1 ITGAX NRP1 ZFHX2 MACF1 SLA2 MAML2 IL2RB UTRN	4.32e-04	376	154	10	GSM605894_500
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	HEXA SGK1 MAZ DAB2 PLXND1 ITGAX NRP1 ZFP36L1 MACF1	4.06e-08	200	157	9	a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 SSPOP HOXA6 COL18A1 ARHGAP31 KIT	3.05e-07	184	157	8	ae0a77e3e520a246b17776bb19503519636b02ee
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ACACB ZDHHC14 GPAM COL18A1 ATXN2 TMEM245 NFAT5 RAB11FIP3	3.18e-07	185	157	8	1d874608aa2062024323512f68889219471b2f00
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RNF213 KMT2C PTPRC KANSL1 MACF1 NFAT5 UTRN TP53BP2	3.60e-07	188	157	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 ACACB ZDHHC14 KANSL1 MAML2 RERE NFAT5 UTRN	3.74e-07	189	157	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 FCHO2 TSC22D1 UBN1 ARHGAP31 MACF1 UTRN CNOT4	4.56e-07	194	157	8	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD3 TROAP SGK1 KNSTRN ACVRL1 E2F8 KIT KNL1	5.13e-07	197	157	8	a41420d4b6d502c2f594c054c7efbb5d4eac83ff
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SGK1 LILRB2 RNF213 ITGAX LILRB1 KMT2C PTPRC UTRN	5.33e-07	198	157	8	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL2L11 DDI2 PROSER1 ACVRL1 PTGIR KIT RAB11FIP3	2.27e-06	168	157	7	de1042267407719f19eb3f580a5df0c9cd0e8273
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF536 ABI3BP PGR MACF1 LTBP2 MAML2 TNS1	2.98e-06	175	157	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ZDHHC14 ITGAX NRP1 TSC22D1 SLA2 TNS1	3.59e-06	180	157	7	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ZDHHC14 ITGAX NRP1 TSC22D1 SLA2 TNS1	3.59e-06	180	157	7	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	CTTNBP2 LILRB2 DAB2 ITGAX NRP1 MITF TNS1	3.59e-06	180	157	7	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN ZDHHC14 ITGAX NRP1 TSC22D1 SLA2 TNS1	3.59e-06	180	157	7	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP CDK19 PLXND1 ACVRL1 PGR TSC22D1 UTRN	4.00e-06	183	157	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 FCHO2 NCOR1 PTPRC MACF1 UTRN EP300	4.15e-06	184	157	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP KNSTRN CECR2 GPAM NPHP4 TMEM108 KNL1	4.45e-06	186	157	7	3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	LILRB2 DAB2 CDH23 FCHO2 ITGAX SSPOP MITF	4.45e-06	186	157	7	a16ecf70271894a842925f232009e2623d16947e
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	TNRC18 KANSL1 ATXN2 TMEM245 RERE NFAT5 UTRN	4.45e-06	186	157	7	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP KNSTRN CECR2 GPAM NPHP4 TMEM108 KNL1	4.45e-06	186	157	7	ec6d0c29e196e374baa96dd3d506f489c959e77e
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TNRC18 KANSL1 ATXN2 TMEM245 RERE NFAT5 UTRN	4.45e-06	186	157	7	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	CTTNBP2 DAB2 FCHO2 NRP1 ZFP36L1 LTBP2 TNS1	4.61e-06	187	157	7	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ABI3BP CDK19 PLXND1 ACVRL1 TSC22D1 ARHGAP31 UTRN	4.78e-06	188	157	7	5bc1537e079c7435196c163bff5f639ea392a33a
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	SGK1 LILRB2 DAB2 FCHO2 ACVRL1 ITGAX NRP1	4.78e-06	188	157	7	e83de94a9b47a6a90e98face887eae031a322af6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 OBSCN COL18A1 ARHGAP31 KIT	5.12e-06	190	157	7	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 OBSCN COL18A1 ARHGAP31 KIT	5.12e-06	190	157	7	be2b184a3559da41ba387ae0fdbeb9ae532868a5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 OBSCN COL18A1 ARHGAP31 KIT	5.12e-06	190	157	7	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	facs-Trachea-nan-3m-Lymphocytic-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 E2F8 PTPRC SLA2 TMEM108 IL2RB KNL1	5.30e-06	191	157	7	c57df363e3a6e61d2bdca1955330f1899b964267
ToppCell	facs-Trachea-nan-3m-Lymphocytic\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 E2F8 PTPRC SLA2 TMEM108 IL2RB KNL1	5.30e-06	191	157	7	89eb4e30052d0d4a2952157ca743291900ce8de2
ToppCell	facs-Trachea-nan-3m-Lymphocytic-T_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 E2F8 PTPRC SLA2 TMEM108 IL2RB KNL1	5.30e-06	191	157	7	0bf575eba311745fb75f9523f7fc81f73848e25d
ToppCell	10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	LILRB2 CDH23 PTGIR LILRB1 UMODL1 SIGLEC10 UTRN	5.30e-06	191	157	7	a862a571625ab7238589ff201e5954f602c3bd7e
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SHROOM3 NRP1 MACF1 MAML2 RERE RAB11FIP3	5.49e-06	192	157	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 COL18A1 ARHGAP31 KIT UTRN	5.68e-06	193	157	7	294cb5b580bb83fe0eb04f112d5507aac35d4d44
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 COL18A1 ARHGAP31 KIT UTRN	5.68e-06	193	157	7	3d3c45d5ff6f3396a1990615aae9fe176e799994
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 PPP6R1 PLXND1 KMT2C PTPRC DYRK1B AGFG2	5.68e-06	193	157	7	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DAB2 PLXND1 NRP1 LENG8 ARHGAP31 KIT	5.87e-06	194	157	7	c8b9551b93a5aed62154b487db90130604a6125c
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 ARPP21 CECR2 GPAM ZFP36L1 TMEM108 KNL1	5.87e-06	194	157	7	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 COL18A1 ARHGAP31 KIT UTRN	5.87e-06	194	157	7	5d0b0d8e96f0e0297a4dba70a05d87081a4eb323
ToppCell	myeloid-CD16+_Monocyte\|myeloid / Lineage and Cell class	LILRB2 CDH23 ITGAX LILRB1 PTPRC SIGLEC10 UTRN	5.87e-06	194	157	7	aeeadfeb01827dbc7de6576c76fb2e41a3c59247
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 COL18A1 ARHGAP31 KIT UTRN	5.87e-06	194	157	7	6ac759828c41ffa974ee82842162caa959351dd1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SGK1 DAB2 FCHO2 LENG8 PTPRC ZFP36L1 SIGLEC10	5.87e-06	194	157	7	5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a
ToppCell	(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells\|(0)_Normal/No_Treatment / Stress and Cell class	SGK1 DAB2 PLXND1 FCHO2 NRP1 ZFP36L1 ARHGAP31	6.07e-06	195	157	7	e8ab3122f81cb22920becd6611cbd9f00db19d50
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SECISBP2L TUT4 IGLV1-47 IGLV1-44 IGLV1-40 PTPRC UTRN	6.07e-06	195	157	7	ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD3 TROAP SGK1 KNSTRN E2F8 KIT KNL1	6.28e-06	196	157	7	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD3 ARPP21 TROAP KNSTRN MAZ E2F8 KNL1	6.28e-06	196	157	7	5ddd314d3def3776dc7da83778d41c6436ca51ac
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	LILRB2 CDH23 ITGAX LILRB1 ZFP36L1 SIGLEC10 MAPK7	6.28e-06	196	157	7	7fe97109a5a06b35fc081a85f341ea78da131323
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 KMT2C PTPRC MACF1 MED23 UTRN EPB41	6.49e-06	197	157	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DAB2 PLXND1 NRP1 ARHGAP31 MACF1 KIT	6.49e-06	197	157	7	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	ABI3BP NRP1 KANSL1 NCOA1 MACF1 NFAT5 CNOT4	6.49e-06	197	157	7	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DAB2 PLXND1 NRP1 ARHGAP31 MACF1 KIT	6.49e-06	197	157	7	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTTNBP2 LILRB2 RNF213 FCHO2 LILRB1 SIGLEC10 UTRN	6.49e-06	197	157	7	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 DAB2 PLXND1 NRP1 ARHGAP31 MACF1 KIT	6.71e-06	198	157	7	f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 EP400 MLLT10 VPS13D KANSL1 TMEM245 MED23	6.93e-06	199	157	7	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERBB2 SGK1 TSC22D1 ZFP36L1 NFAT5 KIT TNS1	6.93e-06	199	157	7	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 KMT2C KANSL1 NCOA1 MAML2 RERE UTRN	6.93e-06	199	157	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Control-NK\|Control / Disease condition and Cell class	ERBB2 DAB2 RNF213 ITGAX MACF1 IL2RB UTRN	6.93e-06	199	157	7	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ERBB2 RNF213 SSBP3 PTPRC MACF1 IL2RB UTRN	6.93e-06	199	157	7	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 GPAM DYRK1B SIGLEC10 AGFG2 KIT IL9R	6.93e-06	199	157	7	6e7f7214317f2af2ba8523df9896f54b7294d58a
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 GPAM DYRK1B SIGLEC10 AGFG2 KIT IL9R	6.93e-06	199	157	7	5f499595597c10857bba8272f62afe4d32d733ac
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ERBB2 RNF213 SSBP3 PTPRC MACF1 IL2RB UTRN	6.93e-06	199	157	7	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	HEXA SGK1 DAB2 PLXND1 FCHO2 NRP1 ZFP36L1	7.16e-06	200	157	7	58ff8db0ecf71daa86f9a38208e0d9b712cac0b5
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 KMT2C PTPRC KANSL1 MACF1 UTRN EPB41	7.16e-06	200	157	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	ZNF536 MCHR1 CECR2 NRP1 RERE ARHGAP21 EPB41	7.16e-06	200	157	7	332905a686356cd1e024d40679be98e9d8b1b5e8
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ZNF536 ERBB4 SGK1 ZFHX4 MAML2 KIT UTRN	7.16e-06	200	157	7	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TUT4 RNF213 ACVRL1 NRP1 KMT2C MACF1 UTRN	7.16e-06	200	157	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Mild-Myeloid-Macrophages-FCN1-SPP1+\|Mild / Condition, Lineage, Cell class and cell subclass	HEXA SGK1 LILRB2 DAB2 FCHO2 ITGAX TNS1	7.16e-06	200	157	7	e5afd8e2cb2c63899d49fe17011f474d20bb06ea
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ZNF536 ERBB4 SGK1 ZFHX4 MAML2 KIT UTRN	7.16e-06	200	157	7	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 SSBP3 PTPRC MACF1 IL2RB UTRN EPB41	7.16e-06	200	157	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ZNF536 ERBB4 SGK1 ZFHX4 MAML2 KIT UTRN	7.16e-06	200	157	7	a91345f268f13170c27309333603eb82400c9947
ToppCell	mild-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ERBB2 RNF213 SSBP3 MEX3C MACF1 IL2RB UTRN	7.16e-06	200	157	7	a11fb1d7e124c352eb73fea0e0ec0fed577c97f7
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	ERBB2 RNF213 SRCAP PTPRC MACF1 IL2RB UTRN	7.16e-06	200	157	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB2 CDH23 ITGAX LILRB1 PTPRC ARHGAP31	1.28e-05	145	157	6	778655fffd73df101e656154a41b478a1b695116
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	RNF213 KMT2C PTPRC KANSL1 MACF1 MAML2	1.94e-05	156	157	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TROAP ZKSCAN7 PTGIR E2F8 TMEM108 IL9R	2.94e-05	168	157	6	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	390C-Lymphocytic-ILC-ILC-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	CC2D1B TNRC18 LRFN4 SLA2 EPS8L3 MED23	2.94e-05	168	157	6	2781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SECISBP2L CREBBP PTPRC ZFP36L1 MACF1 RERE	3.04e-05	169	157	6	c3a6179a64589a370108fea809b157839347759c
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ERBB2 DAB2 ITGAX ARHGAP31 IL2RB UTRN	3.14e-05	170	157	6	81341bf4fe090af70b2091b6b2579ed08d76e22d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TUT4 RNF213 PTPRC KANSL1 MACF1 UTRN	3.24e-05	171	157	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	control-Myeloid-Mast_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 COL18A1 MITF SIGLEC10 KIT IL9R	3.35e-05	172	157	6	c1c99e6732234a6649a79610e99390db0c8f19b0
ToppCell	normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	SGK1 LILRB2 ACVRL1 ITGAX MITF CNGB1	3.46e-05	173	157	6	38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34
ToppCell	wk_15-18-Hematologic-Myeloid-aDC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SGK1 LILRB2 ITGAX LILRB1 ETV3L PTPRC	3.69e-05	175	157	6	c31178d7a5a19d7afd336c9ec0e5c493655a6aa4
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ATF7 TROAP DAB2 PROSER1 NRP1 KNL1	3.69e-05	175	157	6	bde785ff0c854646d7ab8571359e9d69a7bf013f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NCAPD3 TROAP KNSTRN E2F8 TMEM108 KNL1	3.69e-05	175	157	6	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	SGK1 PLXND1 ZFP36L1 KIF19 LTBP2 TNS1	3.93e-05	177	157	6	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	SGK1 PLXND1 PTGIR MED23 TNS1 ARHGAP21	3.93e-05	177	157	6	52c2ba74a8605260a2623e7d151286e504ac4d19
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGK1 CECR2 PLXND1 ARHGAP31 FHOD1 CNGB1	4.06e-05	178	157	6	93ce73f8bcec63ebf86fabb546f88400e8f06465
ToppCell	ASK440-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	BCL2L11 ZDHHC14 UPF1 SIGLEC10 LTBP2 IL2RB	4.06e-05	178	157	6	86f1741636ed3e85bb4a65f84949b718fc38c290
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERBB2 UPF1 LENG8 MACF1 ARHGAP21 WNK2	4.19e-05	179	157	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPD3 TROAP KNSTRN SSTR3 LRFN4 KNL1	4.19e-05	179	157	6	54621d2b3a66e62aa76b7e444118878ed97c1e02
ToppCell	RSV-Healthy-0\|RSV / Virus stimulation, Condition and Cluster	NCOA6 BCL2L11 PTPRC ZFP36L1 DYRK1B UTRN	4.32e-05	180	157	6	974044056e2f7e909cb11c6f6ca89e58bf95f7e5
ToppCell	RSV-Healthy-0\|Healthy / Virus stimulation, Condition and Cluster	NCOA6 BCL2L11 PTPRC ZFP36L1 DYRK1B UTRN	4.32e-05	180	157	6	703a1d0f9536af94d56757eb01221878d7b7fe61
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABI3BP CDK19 PLXND1 PGR TSC22D1 UTRN	4.46e-05	181	157	6	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC14 ITGAX NRP1 TSC22D1 SLA2 TNS1	4.46e-05	181	157	6	782716b8b1d447d2bbe09a693fa5ed7ebeac0efb
ToppCell	facs-Marrow-B-cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC14 ITGAX NRP1 TSC22D1 SLA2 TNS1	4.46e-05	181	157	6	e2481291c236105774c53883e6f20da11941df9b
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 NCOR1 MACF1 KIT IL2RB UTRN	4.60e-05	182	157	6	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NCAPD3 TROAP KNSTRN E2F8 ARHGAP33 KNL1	4.60e-05	182	157	6	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 CECR2 FCHO2 PTPRC MACF1 EP300	4.60e-05	182	157	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 NCOR1 MACF1 KIT IL2RB UTRN	4.60e-05	182	157	6	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3BP PLXND1 ACVRL1 TSC22D1 TNS1 UTRN	4.88e-05	184	157	6	087666ba949b129c53d7ace40f9e543e3875a7de
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF536 ERBB4 SGK1 COL18A1 ARHGAP31 KIT	4.88e-05	184	157	6	e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a
Computational	Genes in the cancer module 85.	ERBB2 ERBB4 NRP1 KIT IL2RB	1.05e-04	51	100	5	MODULE_85
Computational	Genes in the cancer module 199.	ERBB2 ERBB4 NRP1 KIT IL2RB	1.80e-04	57	100	5	MODULE_199
Drug	Dichlorodiphenyldichloroethane	PLXND1 ACVRL1 CREBBP PGR KIT	1.30e-06	29	152	5	ctd:D003632
Drug	Sp 1 (pharmaceutical)	HEXA ZBTB33 MAZ ZKSCAN7 POGZ SRCAP ITGAX LILRB1 PGR NCOR1 MITF NCOA1 MED26 IL2RB EP300	4.22e-06	548	152	15	CID000099040
Drug	Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A	SYN3 MAP4 MLLT10 NRP1 TSC22D1 THPO ZFHX4 TNS1 RAB11FIP3	5.23e-06	189	152	9	3084_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; HL60; HT_HG-U133A	ZNF536 TUT4 MAP4 ITGAX LILRB1 NRP1 CBLIF MAPK7 TNS1	5.46e-06	190	152	9	1342_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MAP4 MLLT10 EML3 ZFHX4 ZFP36L1 RERE NFAT5 UTRN CNOT4	5.94e-06	192	152	9	6054_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A	ACACB DAB2 ACVRL1 HOXA6 RERE NFAT5 KIT TNS1 CNOT4	6.46e-06	194	152	9	2377_UP
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	ZBTB33 MAP4 DAB2 RTN2 PGR ZCCHC14 VPS13D ZFHX4 ZFP36L1	6.74e-06	195	152	9	4742_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	ZDHHC14 PROSER1 NCOR1 LRFN4 NCOA1 NFAT5 UTRN CNOT4 RAB11FIP3	7.02e-06	196	152	9	2367_DN
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A	SGTA ITGAX LILRB1 VPS13D NCOA1 MACF1 TNS1 EP300 CNOT4	7.02e-06	196	152	9	1843_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; HL60; HT_HG-U133A	MAP4 CDK19 SRCAP LILRB1 NRP1 TSC22D1 NFAT5 UTRN CNOT4	7.02e-06	196	152	9	1865_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A	LILRB2 PLXND1 EML3 FARP2 ZCCHC14 CBLIF LTBP2 UTRN ARHGAP33	7.32e-06	197	152	9	6277_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	PROSER1 RTN2 EML3 NCOR1 LRFN4 ZNF335 TNS1 UTRN CNOT4	7.32e-06	197	152	9	5843_UP
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	MAP4 MLLT10 SRCAP FARP2 VPS13D MITF MAPK7 CNOT4 RAB11FIP3	7.32e-06	197	152	9	6428_DN
Drug	Succimer	ERBB4 MCHR1 BCL2L11 DAB2 ZDHHC14 RNF213 MLLT10 ITGAX PTGIR CREBBP E2F8 NRP1 COL18A1 TSC22D1 PTPRC ZFHX4 ZFP36L1 AGFG2 NFAT5 KIT UTRN PRRC1 CNOT4	1.13e-05	1264	152	23	ctd:D004113
Drug	AC1L9M2J	ERBB2 ACVRL1 PGR NCOR1 NCOA1 EP300	1.19e-05	76	152	6	CID000448538
Drug	AC1L19WK	CTTNBP2 FARP2 SAGE1 COASY BAG6	1.36e-05	46	152	5	CID000000734
Drug	ormeloxifene	PGR NCOR1 NCOA1	1.59e-05	8	152	3	ctd:C508548
Drug	Magnetite Nanoparticles	ERBB4 MCHR1 BCL2L11 DAB2 ZDHHC14 RNF213 MLLT10 ITGAX PTGIR CREBBP E2F8 NRP1 COL18A1 TSC22D1 PTPRC ZFHX4 ZFP36L1 AGFG2 NFAT5 KIT UTRN PRRC1 CNOT4	2.00e-05	1310	152	23	ctd:D058185
Drug	butamifos	MCHR1 BCL2L11 SSTR3 RERE	2.55e-05	26	152	4	CID000037419
Drug	androstenol	NCOA6 PTGIR NCOR1 NCOA1	2.97e-05	27	152	4	CID000101989
Drug	vinylene	ZNF536 TUT4 ZBTB33 MAZ ZIM2 ZKSCAN7 NCOR1 ZNF335 EP300	4.12e-05	245	152	9	CID000006326
Drug	tanoproget	PGR NCOA1	4.43e-05	2	152	2	ctd:C503890
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	ZBTB33 NRP1 VPS13D BTBD7 AGFG2 TNS1 CNOT4 ARHGAP33	4.43e-05	191	152	8	3803_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	BCL2L11 MAP4 SGK1 PLXND1 EML3 E2F8 CRKL NCOR1	4.60e-05	192	152	8	2785_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ABHD14A MAP4 SRCAP BTBD7 LTBP2 RERE NFAT5 CNOT4	4.77e-05	193	152	8	1464_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	MAP4 SRCAP ZCCHC14 VPS13D ZFHX4 MITF RERE KIT	4.77e-05	193	152	8	3378_DN
Drug	splitomicin; Up 200; 20uM; PC3; HG-U133A	MAP4 SGTA ZIM2 POGZ NRP1 TSC22D1 VPS13D ZNF335	4.95e-05	194	152	8	661_UP
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	SRCAP ITGAX PTGIR NRP1 ZFP36L1 BTBD7 TNS1 CNOT4	4.95e-05	194	152	8	4092_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SECISBP2L ACACB EP400 ABI3BP DAB2 MLLT10 NRP1 CNOT4	4.95e-05	194	152	8	4662_DN
Drug	Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	TUT4 EP400 MAZ NRP1 CBLIF ZFP36L1 BTBD7 RERE	5.13e-05	195	152	8	4577_UP
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAP4 SGK1 EML3 ATXN2 MITF RCOR3 NFAT5 CNOT4	5.13e-05	195	152	8	7404_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; HL60; HT_HG-U133A	TUT4 ACACB POGZ LILRB1 EML3 VPS13D LRFN4 RERE	5.13e-05	195	152	8	1859_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	ACACB ZDHHC14 SRCAP PTGIR BTBD7 AGFG2 IL2RB CNOT4	5.13e-05	195	152	8	3124_UP
Drug	Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A	MAP4 CDK19 CBLIF ZFHX4 EPS8L3 MAPK7 TNS1 UTRN	5.13e-05	195	152	8	5451_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	CDK19 SRCAP HOXA6 VPS13D ZFP36L1 FHOD1 CNOT4 ARHGAP33	5.13e-05	195	152	8	2875_UP
Drug	Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ACACB CDK19 ZIM2 CRKL ZFP36L1 MAPK7 TNS1 CNOT4	5.32e-05	196	152	8	3238_UP
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A	MAP4 SREBF1 ZDHHC14 PLXND1 EML3 YEATS2 UTRN CNOT4	5.32e-05	196	152	8	2377_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; HL60; HT_HG-U133A	ZDHHC14 PLXND1 CRKL FARP2 AGFG2 LTBP2 MAPK7 CNOT4	5.32e-05	196	152	8	3134_DN
Drug	Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A	ABHD14A BCL2L11 MAP4 SGTA ZDHHC14 LILRB1 RABL6 ZFP36L1	5.32e-05	196	152	8	2963_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A	UPF1 RTN2 NCOR1 VPS13D BTBD7 FHOD1 MACF1 CNOT4	5.32e-05	196	152	8	2361_DN
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	MAP4 ZDHHC14 RTN2 EML3 RABL6 VPS13D LRFN4 FHOD1	5.32e-05	196	152	8	2406_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	BCL2L11 PLXND1 MLLT10 EML3 ZFHX2 SMARCD3 MAPK7 CNOT4	5.32e-05	196	152	8	5734_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A	ACACB SGTA SRCAP MSL2 VPS13D ATXN2 SMARCD3 UTRN	5.32e-05	196	152	8	1912_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ACACB MAP4 PLXND1 RTN2 VPS13D ZFP36L1 AGFG2 ARHGAP33	5.52e-05	197	152	8	2328_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	UPF1 MLLT10 RABL6 CBLIF BTBD7 MAPK7 NFAT5 ARHGAP33	5.52e-05	197	152	8	2228_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	ZBTB33 ZIM2 SRCAP NRP1 VPS13D ZFP36L1 ZFHX2 TNS1	5.52e-05	197	152	8	5001_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	MAP4 MAZ SREBF1 EML3 YEATS2 LRFN4 RERE ARHGAP33	5.52e-05	197	152	8	2766_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; HL60; HT_HG-U133A	SECISBP2L MAP4 MAZ SREBF1 PLXND1 SRCAP UTRN RAB11FIP3	5.72e-05	198	152	8	2333_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	ERBB2 EP400 MAP4 SRCAP E2F8 HOXA6 VPS13D TNS1	5.72e-05	198	152	8	6353_DN
Drug	Sulfaphenazole [526-08-9]; Up 200; 12.8uM; HL60; HT_HG-U133A	SECISBP2L LILRB2 LILRB1 EML3 NRP1 ZFHX4 ZFP36L1 ZFHX2	5.72e-05	198	152	8	1836_UP
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	MAP4 ZDHHC14 MLLT10 CRKL HOXA6 THPO NCOA1 CNOT4	5.72e-05	198	152	8	3018_DN
Drug	5248896; Down 200; 11uM; MCF7; HT_HG-U133A_EA	SECISBP2L MAP4 CDK19 MLLT10 E2F8 NCOA1 MACF1 NFAT5	5.72e-05	198	152	8	955_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	MAP4 CDK19 PLXND1 EML3 BTBD7 AGFG2 RERE UTRN	5.72e-05	198	152	8	1503_DN
Drug	Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A	MAZ MLLT10 RTN2 EML3 VPS13D ZFP36L1 MAPK7 TNS1	5.72e-05	198	152	8	4074_DN
Drug	Cisapride [81098-60-4]; Up 200; 8.6uM; HL60; HT_HG-U133A	ERBB2 TUT4 LILRB2 THPO ZFHX4 EPS8L3 RERE MAPK7	5.92e-05	199	152	8	2443_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	TUT4 ZDHHC14 SRCAP CREBBP ZFP36L1 BTBD7 RERE TNS1	5.92e-05	199	152	8	3860_DN
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ZBTB33 ABI3BP SGK1 SRCAP PGR RERE TNS1 UTRN	5.92e-05	199	152	8	6489_UP
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HG-U133A	MAP4 SGTA UPF1 VPS13D MITF RCOR3 MAPK7 RAB11FIP3	5.92e-05	199	152	8	1907_DN
Drug	radicicol; Down 200; 0.1uM; PC3; HG-U133A	SREBF1 MLLT10 RTN2 EML3 MSL2 VPS13D ATXN2 TNS1	5.92e-05	199	152	8	484_DN
Drug	FK-506; Up 200; 1uM; MCF7; HG-U133A	ERBB2 CDK19 SRCAP CREBBP VPS13D SS18L1 SMARCD3 EPS8L3	5.92e-05	199	152	8	169_UP
Drug	Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A	ATF7 ACACB DAB2 ZDHHC14 HOXA6 VPS13D SMARCD3 RERE	5.92e-05	199	152	8	5995_UP
Drug	Sparteine (-) [90-39-1]; Up 200; 17uM; HL60; HT_HG-U133A	ATF7 ACACB MAP4 EML3 HOXA6 CBLIF ZFHX4 UTRN	6.14e-05	200	152	8	2134_UP
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; HL60; HT_HG-U133A	MAP4 MAZ CDK19 MLLT10 ITGAX ZFP36L1 NFAT5 PRRC1	6.14e-05	200	152	8	1846_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A	SGTA POGZ PLXND1 VPS13D FHOD1 NCOA1 EP300 RAB11FIP3	6.14e-05	200	152	8	1278_DN
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; HL60; HG-U133A	SGK1 CDK19 ACVRL1 ZCCHC14 FHOD1 SS18L1 EP300 PRRC1	6.14e-05	200	152	8	1570_UP
Drug	phosphotyrosine (pY	ERBB2 ERBB4 PTPRC TMEM245 C6orf15 RERE EP300 TP53BP2	6.81e-05	203	152	8	CID000030819
Drug	phorbol-13-acetate	ERBB4 ITGAX PTGIR E2F8 PGR ZFP36L1 NCOA1 IL2RB EP300 EPB41	7.04e-05	326	152	10	CID000499953
Drug	Aldrin	MAP4 SREBF1 GPAM PLXND1 ACVRL1 PGR TSC22D1 KIT	7.81e-05	207	152	8	ctd:D000452
Drug	TO-901317	ACACB SREBF1 GPAM NCOR1 TSC22D1 NCOA1	7.90e-05	106	152	6	ctd:C423915
Drug	steroid D	MAP4 NCOR1 NCOA1	7.94e-05	13	152	3	CID000454475
Drug	Cyproterone Acetate	CREBBP PGR NCOR1 NCOA1	8.51e-05	35	152	4	ctd:D017373
Drug	dimefox	MCHR1 BCL2L11 SSTR3 RERE	8.51e-05	35	152	4	CID000008264
Drug	2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene	ACVRL1 CREBBP PGR KIT	9.52e-05	36	152	4	ctd:C054919
Drug	L-165041	PTGIR NCOR1 NCOA1 EP300	9.52e-05	36	152	4	CID006603901
Drug	L-817,818	MCHR1 BCL2L11 SSTR3	1.25e-04	15	152	3	CID005311375
Drug	hydroxyethylretinamide	ERBB2 ERBB4 PGR NCOR1 NCOA1	1.29e-04	73	152	5	CID006437840
Drug	trimegestone	PGR NCOA1	1.32e-04	3	152	2	ctd:C050319
Drug	pyrido[3,4-d]pyrimidine	ERBB2 ERBB4	1.32e-04	3	152	2	CID014758064
Drug	ABT-737	ERBB2 PGR	1.32e-04	3	152	2	CID011228183
Drug	L-796,778	MCHR1 BCL2L11 SSTR3	1.53e-04	16	152	3	CID005311373
Drug	4-anilinoquinazoline	ERBB2 ERBB4 KIT	1.53e-04	16	152	3	CID000324081
Drug	4-methylbenzylidene camphor	PGR NCOR1 NCOA1	1.53e-04	16	152	3	CID006434217
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; HL60; HG-U133A	SGK1 CREBBP ZCCHC14 ZNF335 RCOR3 RERE NFAT5	1.60e-04	172	152	7	1998_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA6 CREBBP E2F8 MEX3C NRP1 ZFP36L1 EP300	1.60e-04	172	152	7	1072_DN
Drug	polyproline	SGTA NCK1 MLLT10 CRKL PGR ZFP36L1 SLA2 BAG6 TP53BP2	1.70e-04	295	152	9	CID000439587
Drug	Aldosterone	NCOA6 SGK1 DAB2 CREBBP NCOA1	1.88e-04	79	152	5	ctd:D000450
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	BCL2L11 LILRB2 SREBF1 RTN2 FARP2 TNS1 RAB11FIP3	1.98e-04	178	152	7	4483_UP
Drug	Dichlorodiphenyl Dichloroethylene	ERBB2 ERBB4 BCL2L11 SREBF1 PLXND1 ACVRL1 CREBBP PGR KIT	2.02e-04	302	152	9	ctd:D003633
Drug	beta-hexachlorocyclohexane	ERBB2 SREBF1 SRCAP PGR TNS1 EPB41	2.04e-04	126	152	6	ctd:C023888
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A	BCL2L11 ZIM2 SRCAP CRKL HOXA6 RERE CNOT4	2.05e-04	179	152	7	3630_UP
Drug	staurosporine; Down 200; 1uM; MCF7; HG-U133A	ADNP2 POGZ E2F8 CRKL MSL2 TSC22D1 ZFP36L1	2.19e-04	181	152	7	312_DN
Drug	L-803,087	MCHR1 BCL2L11 SSTR3	2.21e-04	18	152	3	CID005311374
Drug	Aa1	THPO PTPRC C6orf15 NCOA1 EPB41	2.37e-04	83	152	5	CID009549188
Drug	k143	PGR NCOA1 TP53BP2	2.61e-04	19	152	3	CID000590836
Drug	halofenate	NCOR1 EP300	2.63e-04	4	152	2	CID000033584
Drug	3-aminopyrrolidine	MCHR1 PGR	2.63e-04	4	152	2	CID000164401
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	BCL2L11 MAP4 PLXND1 SRCAP VPS13D LRFN4 TNS1	2.76e-04	188	152	7	6195_DN
Drug	Peony	SGTA PRB1 SAGE1	3.06e-04	20	152	3	CID005483934
Drug	BPD-MA	ITGAX PTPRC IL2RB	3.06e-04	20	152	3	CID005485223
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	ZDHHC14 E2F8 FARP2 BTBD7 AGFG2 TNS1 RAB11FIP3	3.14e-04	192	152	7	4450_DN
Disease	cortical thickness	ZNF536 SHROOM3 CTTNBP2 SREBF1 PLXND1 MLLT10 SSBP3 ETV3L NRP1 COL18A1 VPS13D KANSL1 UBN1 ATXN2 UMODL1 MITF MACF1 TMEM108 RERE TNS1 ARHGAP21 INS-IGF2 WNK2 CRB2	2.95e-09	1113	152	24	EFO_0004840
Disease	cortical surface area measurement	NCAPD3 ZNF536 SHROOM3 ADAMTSL1 CTTNBP2 SREBF1 PLXND1 FCHO2 SSBP3 CRKL NRP1 NCOR1 KANSL1 ATXN2 ARHGAP31 C6orf15 MACF1 RERE MED23 KIT TNS1 ARHGAP21 CNOT4 INS-IGF2 WNK2	2.54e-08	1345	152	25	EFO_0010736
Disease	testosterone measurement	NCOA6 ZNF536 SHROOM3 BCL2L11 KNSTRN CECR2 GPAM IQCN SRCAP MSL2 FARP2 ZFHX4 ZFP36L1 RTL9 AGFG2 NCOA1 MACF1 MED23 UTRN ARHGAP21 INS-IGF2 KNL1	6.76e-07	1275	152	22	EFO_0004908
Disease	type 1 diabetes mellitus	NRP1 FARP2 PTPRC ZFP36L1 ATXN2 NCOA1 PAX4 IL2RB INS-IGF2	4.90e-06	242	152	9	MONDO_0005147
Disease	alkaline phosphatase measurement	ATF7 ADAMTSL1 ACACB MAP4 GPAM NCK1 FCHO2 SSBP3 FARP2 KANSL1 ATXN2 SS18L1 MITF MACF1 LTBP2 NFAT5 UTRN ARHGAP21	5.26e-06	1015	152	18	EFO_0004533
Disease	neuroimaging measurement	SECISBP2L SHROOM3 CTTNBP2 PLXND1 MLLT10 SSBP3 NRP1 NCOR1 COL18A1 KANSL1 ATXN2 MITF MACF1 RERE TNS1 INS-IGF2 WNK2 CRTC2	1.06e-05	1069	152	18	EFO_0004346
Disease	Adenoid Cystic Carcinoma	ZIM2 SRCAP CREBBP KMT2C KANSL1 EP300	1.35e-05	100	152	6	C0010606
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	2.64e-05	2	152	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	2.64e-05	2	152	2	cv:C4551859
Disease	Menke-Hennekam syndrome	CREBBP EP300	2.64e-05	2	152	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	2.64e-05	2	152	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	2.64e-05	2	152	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	2.64e-05	2	152	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	2.64e-05	2	152	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	2.64e-05	2	152	2	C0035934
Disease	melanoma	ERBB4 GPAM MLLT10 MITF PAX4 KIT EP300 EPB41	4.60e-05	248	152	8	C0025202
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	LILRB1 LENG8 C6orf15	5.83e-05	15	152	3	EFO_0008208
Disease	Neoplasm of uncertain or unknown behavior of breast	ERBB2 ERBB4 NCOR1 EP300	5.91e-05	41	152	4	C0496956
Disease	Breast adenocarcinoma	ERBB2 ERBB4 NCOR1 EP300	5.91e-05	41	152	4	C0858252
Disease	Carcinoma, Transitional Cell	CREBBP NCOR1 KMT2C EP300	5.91e-05	41	152	4	C0007138
Disease	small cell lung carcinoma	ADAMTSL1 FCHO2 NRP1 C6orf15 BAG6	5.98e-05	80	152	5	EFO_0000702
Disease	waist-hip ratio	ERBB4 ARPP21 BCL2L11 DAB2 IQCN PLXND1 MLLT10 NRP1 YEATS2 COL18A1 UBN1 ATXN2 LTBP2 RERE NFAT5 ARHGAP21 INS-IGF2 KNL1	6.40e-05	1226	152	18	EFO_0004343
Disease	systemic lupus erythematosus	ERBB2 ERBB4 SHROOM3 BCL2L11 DAB2 CDH23 IQCN SRCAP ITGAX PTPRC ATXN2 ARHGAP31 RERE KIT	7.05e-05	799	152	14	MONDO_0007915
Disease	serine/threonine-protein kinase receptor R3 measurement	ACVRL1 IGLV1-44	7.88e-05	3	152	2	EFO_0020733
Disease	response to thiazide, QT interval	ADAMTSL1 CREBBP	7.88e-05	3	152	2	EFO_0004682, EFO_0007981
Disease	retinal vasculature measurement	ERBB4 ZDHHC14 FARP2 THPO ATXN2 MITF AGFG2 LTBP2 TNS1 CRB2 KNL1	8.08e-05	517	152	11	EFO_0010554
Disease	fibrinogen measurement, tissue plasminogen activator measurement	PLXND1 FARP2 ZFP36L1 ATXN2	8.56e-05	45	152	4	EFO_0004623, EFO_0004791
Disease	neuroimaging measurement, brain volume measurement	CTTNBP2 MLLT10 SSBP3 KANSL1 MITF NFAT5 WNK2 CRB2	1.24e-04	286	152	8	EFO_0004346, EFO_0006930
Disease	C-reactive protein measurement	NCOA6 ZNF536 ERBB4 ARPP21 MLLT10 SSPOP EML3 MSL2 FARP2 YEATS2 NCOR1 MACF1 RERE NFAT5 KIT ARHGAP21 ARHGAP33	1.68e-04	1206	152	17	EFO_0004458
Disease	Endometrioma	NCOA6 ABI3BP PGR NRP1 NCOR1 NCOA1	1.93e-04	161	152	6	C0269102
Disease	Endometriosis	NCOA6 ABI3BP PGR NRP1 NCOR1 NCOA1	1.93e-04	161	152	6	C0014175
Disease	sodium measurement	ARPP21 MLLT10 SSBP3 BTBD7 NFAT5	1.98e-04	103	152	5	EFO_0009282
Disease	stomach carcinoma (is_marker_for)	ERBB2 ERBB4 KMT2C	2.51e-04	24	152	3	DOID:5517 (is_marker_for)
Disease	mean reticulocyte volume	SYN3 BCL2L11 EP400 E2F8 PTPRC KANSL1 ZFP36L1 ATXN2 AGFG2 RCOR3 BAG6 ARHGAP21 EPB41	2.65e-04	799	152	13	EFO_0010701
Disease	neuroticism measurement	ZNF536 ERBB4 ARPP21 CTTNBP2 MCHR1 NCK1 ACVRL1 MSL2 ZCCHC14 KANSL1 C6orf15 LTBP2 RERE BAG6	2.68e-04	909	152	14	EFO_0007660
Disease	Leukemia, Myelocytic, Acute	SGK1 MLLT10 CREBBP KMT2C KIT EP300	2.85e-04	173	152	6	C0023467
Disease	Malignant neoplasm of breast	NCOA6 ERBB2 ERBB4 OBSCN MAGEE1 PGR ZCCHC14 NCOR1 PTPRC NCOA1 MACF1 KIT TNS1 EP300 TP53BP2	4.54e-04	1074	152	15	C0006142
Disease	coronary artery disease	NCOA6 ERBB4 SHROOM3 SYN3 SREBF1 RNF213 ACVRL1 NRP1 MSL2 ATXN2 ZNF335 MITF NFAT5 TNS1 ARHGAP21 WNK2	4.60e-04	1194	152	16	EFO_0001645
Disease	apolipoprotein A 1 measurement	ACACB LILRB2 GPAM NCK1 NRP1 MSL2 FARP2 COL18A1 ZFP36L1 ATXN2 MACF1 MED23 KIT	4.66e-04	848	152	13	EFO_0004614
Disease	thyroid peroxidase antibody measurement	CTTNBP2 THPO ATXN2 RERE	5.30e-04	72	152	4	EFO_0005666
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 ERBB4 SREBF1 CREBBP SMARCD3 EP300	5.38e-04	195	152	6	DOID:1574 (implicated_via_orthology)
Disease	Intellectual Disability	HEXA POGZ RABL6 COL18A1 KMT2C KANSL1 ZNF335 MACF1 MED23	5.40e-04	447	152	9	C3714756
Disease	platelet component distribution width	ZDHHC14 NCK1 SSBP3 CRKL COL18A1 PTPRC ZFP36L1 ATXN2 BTBD7 MACF1 EPB41 RAB11FIP3	5.63e-04	755	152	12	EFO_0007984
Disease	blood urea nitrogen measurement	SHROOM3 NCK1 FCHO2 ACVRL1 SSBP3 ATXN2 RCOR3 NFAT5 INS-IGF2	5.85e-04	452	152	9	EFO_0004741
Disease	brain measurement, neuroimaging measurement	CTTNBP2 MLLT10 SSBP3 NRP1 COL18A1 KANSL1 MITF MACF1 TNS1 WNK2	5.90e-04	550	152	10	EFO_0004346, EFO_0004464
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	IQCN MLLT10 EML3 UBN1 MACF1 RERE COASY NFAT5	6.24e-04	364	152	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	head and neck squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4	7.23e-04	8	152	2	DOID:5520 (is_marker_for)
Disease	latent autoimmune diabetes in adults, type 2 diabetes mellitus	ATXN2 INS-IGF2	9.27e-04	9	152	2	EFO_0009706, MONDO_0005148
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SHROOM3 GPAM ATXN2 ZNF335 MACF1 NFAT5	1.06e-03	222	152	6	EFO_0008317, EFO_0020943
Disease	ductal carcinoma in situ (is_marker_for)	ERBB2 ERBB4 PGR	1.07e-03	39	152	3	DOID:0060074 (is_marker_for)
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	SHROOM3 GPAM MSL2 ATXN2 MACF1	1.10e-03	150	152	5	EFO_0004611, EFO_0020947
Disease	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	ZFP36L1 ATXN2 IL2RB	1.15e-03	40	152	3	EFO_1001999, EFO_1002019, EFO_1002020
Disease	neutrophil percentage of granulocytes	BCL2L11 FARP2 PTPRC KANSL1 ATXN2 RERE	1.21e-03	228	152	6	EFO_0007994
Disease	Cutaneous Melanoma	ERBB4 MITF KIT	1.24e-03	41	152	3	C0151779
Disease	Mammary Neoplasms, Experimental	ERBB2 SGK1 PGR TSC22D1 NCOA1	1.28e-03	155	152	5	C0024668
Disease	prostate cancer (is_marker_for)	ERBB4 KMT2C NCOA1 MAPK7 EP300	1.31e-03	156	152	5	DOID:10283 (is_marker_for)
Disease	eosinophil percentage of granulocytes	BCL2L11 FARP2 PTPRC KANSL1 ATXN2 RERE	1.38e-03	234	152	6	EFO_0007996
Disease	granulosa cell tumor (is_marker_for)	SGK1 KIT	1.41e-03	11	152	2	DOID:2999 (is_marker_for)
Disease	leukocyte immunoglobulin-like receptor subfamily B member 2 measurement	LILRB2 LILRB1	1.41e-03	11	152	2	EFO_0008209
Disease	gallbladder neoplasm	ERBB2 ERBB4	1.41e-03	11	152	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB2 ERBB4	1.41e-03	11	152	2	C0153452
Disease	Adenocarcinoma of large intestine	ERBB2 ERBB4 KIT EP300	1.56e-03	96	152	4	C1319315
Disease	calcium measurement	SECISBP2L NCOA6 MCHR1 SGK1 SREBF1 FCHO2 MSL2 FARP2 RTL9 MACF1	1.60e-03	628	152	10	EFO_0004838
Disease	basophil count, eosinophil count	BCL2L11 FARP2 PTPRC KANSL1 ATXN2 RERE	1.60e-03	241	152	6	EFO_0004842, EFO_0005090
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	FARP2 ZFP36L1 ATXN2	1.62e-03	45	152	3	EFO_0004623, EFO_0004792
Disease	Clear Cell Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0431121
Disease	Intraventricular Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1334271
Disease	Benign Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0281784
Disease	Intraorbital Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1334261
Disease	Olfactory Groove Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1335107
Disease	Angioblastic Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1527197
Disease	Meningiomas, Multiple	MLLT10 PGR	1.68e-03	12	152	2	C0205834
Disease	Xanthomatous Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0457190
Disease	Angiomatous Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334608
Disease	Psammomatous Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334607
Disease	Fibrous Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334606
Disease	Meningothelial meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334605
Disease	Hemangioblastic Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334609
Disease	Transitional Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334611
Disease	Hemangiopericytic Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0334610
Disease	Spinal Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0347515
Disease	Intracranial Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0349604
Disease	Papillary Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C3163622
Disease	Malignant Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0259785
Disease	Sphenoid Wing Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1565951
Disease	Posterior Fossa Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1565950
Disease	Parasagittal Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0751304
Disease	Cerebral Convexity Meningioma	MLLT10 PGR	1.68e-03	12	152	2	C0751303
Disease	Microcystic meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1384408
Disease	Secretory meningioma	MLLT10 PGR	1.68e-03	12	152	2	C1384406
Disease	Vitiligo	FARP2 PTPRC ATXN2 RERE	1.88e-03	101	152	4	EFO_0004208
Disease	Glaucoma, Primary Open Angle	ATXN2 TP53BP2	1.98e-03	13	152	2	C0339573
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 ERBB4 KMT2C	2.08e-03	49	152	3	DOID:3910 (is_implicated_in)
Disease	developmental disorder of mental health (implicated_via_orthology)	PLXND1 SRCAP NCOR1	2.08e-03	49	152	3	DOID:0060037 (implicated_via_orthology)
Disease	blood phosphate measurement	ADAMTSL1 SYN3 ATXN2 MED23 KNL1	2.12e-03	174	152	5	EFO_0010972
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	CREBBP SS18L1 OTOG	2.20e-03	50	152	3	C1862939
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 ERBB4	2.30e-03	14	152	2	DOID:571 (biomarker_via_orthology)
Disease	gallstones	SHROOM3 MLLT10 FARP2 NFAT5	2.40e-03	108	152	4	EFO_0004210
Disease	urinary albumin to creatinine ratio	SHROOM3 BCL2L11 MLLT10 ZFP36L1 ARHGAP33	2.40e-03	179	152	5	EFO_0007778
Disease	lymphocyte percentage of leukocytes	ATF7 CECR2 CDH23 MSL2 PTPRC KANSL1 ATXN2 UMODL1 RERE KIT	2.43e-03	665	152	10	EFO_0007993

Protein segments in the cluster

Peptide	Gene	Start	Entry
AAFVQGTSPTPQGLP	UMODL1	966	Q5DID0
DLQSGPSQSPAPVQV	C2orf16	1216	Q68DN1
DPLNNTTPVTGASPG	ERBB2	121	P04626
EPLTPSGTAPNQAQL	ERBB4	696	Q15303
AAGQVTPPTPPQTAQ	EP300	1901	Q09472
VQTQSPTQPSPGPGQ	EP400	131	Q96L91
AQTTAQASTPGQPPP	EP400	1556	Q96L91
TLNINGQIPTGEGPP	EPB41	716	P11171
PPPQQNSTQTNGTAG	CDK19	396	Q9BWU1
QTLGQQVPGFPTAPT	BAG6	486	P46379
GPSPVSLGNQDTLPV	FCHO2	531	Q0JRZ9
IPAGGITTDQQPPNL	CREBBP	531	Q92793
GAPTSLQTEPQGNPE	BCL2L11	31	O43521
TQPPSEQPGTDGQLA	ACVRL1	106	P37023
AQPQVSPAQPTPSTG	ATF7	306	P17544
NSPAGTPLTVLNGPI	CDH23	1971	Q9H251
PGSLQLGQISGPSQD	CECR2	726	Q9BXF3
QNAATPPSTDPGLTG	CECR2	1116	Q9BXF3
SASSLPGTGAQLPPQ	DYRK1B	531	Q9Y463
SSITEPEGPNGPNIQ	TP53BP2	736	Q13625
FSGSGPPISQQVLQP	ARPP21	606	Q9UBL0
LPQNSPSPAAGQPVT	ADNP2	296	Q6IQ32
GGQQPPSLIGIQTDS	RCOR3	476	Q9P2K3
LAANGQSPSPGSQSP	RABL6	286	Q3YEC7
QGPGSPPQPSDLSQT	RAB11FIP3	176	O75154
QSSPLLQPPAAQGTP	IQCN	206	Q9H0B3
GQIAPENGTQTPSPP	ITGAX	1146	P20702
PNVTVLAGLTPGNSP	ABHD14A	66	Q9BUJ0
PSPELQANGTGTQGL	ACACB	111	O00763
PSGQASPTGQPTALQ	DAB2	466	P98082
AQPTGPQPQSAGSTS	MAPK7	611	Q13164
PGPVPTSGVTDTQNT	KMT2C	2356	Q8NEZ4
VNPTFPGSLPSGQDS	HOXA6	6	P31267
PGSDVPQGPSDSQIL	MAGEE1	41	Q9HCI5
PVVSGTGNDITTPPN	MAP4	676	P27816
QNNPLTSGLEPSPPQ	NCK1	251	P16333
PVDVQTLNSSGPPFG	KIT	456	P10721
ISGTAQDGNTEPLPP	ZBTB33	126	Q86T24
SVLTQPPSVSGAPGQ	IGLV1-50	21	A0A075B6I6
PLPLDNSSQPSELGG	CRB2	781	Q5IJ48
NSIGNTPSGPVLASP	ATXN2	696	Q99700
SGPQPGTAPATQHSQ	LENG8	181	Q96PV6
GPNLPSVLTSPLGTQ	ADAMTSL1	1391	Q8N6G6
LLSPLAPVPTGGSQN	PLXND1	756	Q9Y4D7
SVLTQPPSASGTPGQ	IGLV1-47	21	P01700
PLALAGPSSTPQENG	COL18A1	151	P39060
SNILEPLQPGTPGTQ	EPS8L3	501	Q8TE67
SVLTQPPSASGTPGQ	IGLV1-44	21	P01699
GSPAPQSNQVPVSLP	MED23	1351	Q9ULK4
TPQLGSANPSTPQPA	KANSL1	956	Q7Z3B3
QPLTPTGSDPQSGLG	LILRB2	441	Q8N423
GAEGVPVSSQPLPSQ	MAZ	461	P56270
QTQSPTQPSPGPGQA	EP400P1	121	Q6ZTU2
NLPGNFTVNTPPTPE	KNL1	1916	Q8NG31
GSPGAAITPLPSTQN	CRKL	221	P46109
NSSPLPTNGISGSPE	MED26	176	O95402
SLQPIATVPNGGTTP	MSL2	381	Q9HCI7
LQNPGPTQSESSQTP	NFAT5	1336	O94916
PGIQGATSSPQPQAT	NFAT5	1406	O94916
ATSGGQSPTGEQIPQ	MACF1	5586	Q9UPN3
AAPQNSPVGPGLSIS	NPHP4	491	O75161
PGIISAQQSPGSVPT	PAX4	251	O43316
GNPSLNPSVSLPGSL	PROSER1	711	Q86XN7
PSQNTGPGDSSPLAV	KIF19	951	Q2TAC6
APALQETGSQPPVTG	OBSCN	6261	Q5VST9
HSVVGQNTGPSPSPN	MAML2	716	Q8IZL2
SPLSATQGATPQQPP	NCOA6	1171	Q14686
EAPTAGPTTPNGNLV	NRP1	586	O14786
DTLLAPSGPGQSQPS	PGR	116	P06401
SQQECGGTPPASQSP	ARHGAP33	916	O14559
TDFTLPSQTQTPPGG	UPF1	36	Q92900
FGLPGPSQTNLPNSQ	UPF1	1036	Q92900
GTNLPQLGQPSSTGP	C6orf15	41	Q6UXA7
NPGPGPTSASNITVI	CBLIF	301	P27352
PNVQLSASPGSGIVP	E2F8	746	A0AVK6
APPTAQTPGIAPQNS	CTTNBP2	406	Q8WZ74
PPASQIPGLSNLGDS	C7orf57	36	Q8NEG2
PSQSCSVQSSGGQPP	CRTC2	511	Q53ET0
TGSSPQPLQPLSGED	IL2RB	401	P14784
NPSQPETSLPGISAQ	CC2D1B	256	Q5T0F9
ELSQSVSEAGPGPPQ	BTBD7	896	Q9P203
PQSPPAGTLSGLSQT	LTBP2	271	Q14767
LLPTGPNASNTSDGP	MCHR1	76	Q99705
GQPQPRSSETNGSPS	KLHDC7B	61	Q96G42
LQVPPSSLQGSGTPA	EML3	46	Q32P44
QPPGTQQSHSSPGEI	DDI2	111	Q5TDH0
SPGEITSSPQGLDNP	DDI2	121	Q5TDH0
SPVGPPSGLQASVNL	FHOD1	406	Q9Y613
EQLTGQQTPRGPPET	ETV3L	176	Q6ZN32
APSIVQDGPQPSSGL	FARP2	1031	O94887
GSATTQEPPQLQSTP	PIWIL3	31	Q7Z3Z3
SSPQPQGSESLPAQP	INS-IGF2	151	F8WCM5
EQAPNQPPGPTTSSL	OTOG	316	Q6ZRI0
SEPSGTFGPVNPSLN	HEXA	281	P06865
TSPQPTSTQNSGGIP	RTL9	281	Q8NET4
EVLTPQLSPGSGTPQ	RTN2	201	O75298
LSPQGQQPLSPQSGS	SYN3	461	O14994
PQSGSPQQQRSPGSP	SYN3	471	O14994
LGGESPVSQPQSPAQ	UTRN	3236	P46939
PSVTSQNPTVQPGGE	TNRC6C	366	Q9HCJ0
NSPNNISGISNPPGT	SSBP3	346	Q9BWW4
TQAALLGAPTQGPSP	SSPOP	2091	A2VEC9
LPSPSLSSSVQGQGP	SLA2	11	Q9H6Q3
NPLGTPGTSPSQNDL	SGTA	256	O43765
QITQPGTSGQERPPS	SSTR3	376	P32745
DQPLTPTGSDPQSGL	LILRB1	441	Q8NHL6
SVLTQPPSVSGAPGQ	IGLV1-40	21	P01703
GTQKPTSGPQTPQAQ	NCOA1	1416	Q15788
ASVLPGPDGNINSPT	POGZ	1326	Q7Z3K3
GPTSTPPNLISQEQL	GPAM	601	Q9HCL2
TQGTPALPQTGIPTE	NCOR1	1166	O75376
PPSPSQQINLGPSSN	SGK1	76	O00141
PPAATASQTQQIPGG	MEX3C	146	Q5U5Q3
PPSALSGGQPADTQT	KNSTRN	91	Q9Y448
PGQSQAQSQGQPVPT	SMARCD3	76	Q6STE5
GSLGGQPAPIQTQSL	SHROOM3	1626	Q8TF72
PNDNGSVSGVEPTPI	SECISBP2L	36	Q93073
PSGTGLLPTPITQQA	PRRC1	161	Q96M27
LQPLTGSAGQPSAPS	RERE	826	Q9P2R6
QGAPPSSQVVPPAQT	TSC22D1	756	Q15714
GSPPATTQPQGTTQP	TSC22D1	1046	Q15714
PLQTITNENPSGPSL	HERC2P3	491	Q9BVR0
TNENPSGPSLGTIPQ	HERC2P3	496	Q9BVR0
ALPGNTQSSGPIPAL	IL9R	456	Q01113
PSQTLSLGTGNPQGP	SRCAP	1696	Q6ZRS2
SLGTGNPQGPFPTQT	SRCAP	1701	Q6ZRS2
NPQGPFPTQTLSLTP	SRCAP	1706	Q6ZRS2
GFSTGSPPGNTQQPL	SREBF1	171	P36956
ALSTPPPAGQSPAQQ	MLLT10	846	P55197
QAQPTPAGSSQGTPF	AGFG2	286	O95081
QGSSEAPASQPPPQV	NCAPD3	896	P42695
SLEGPAQPQSSPVQA	COASY	46	Q13057
PAPEPQPGSQAQTSS	CNGB1	231	Q14028
SQQISNSDTPSPPPG	CNOT4	291	O95628
TGLPPSSLLQGQIGN	SS18L1	111	O75177
SQAQQSGPTGQPSQP	RNF213	136	Q63HN8
PSSGSPLLSQLGQPS	TNRC18	136	O15417
EESPSLIAGNPQGPS	PRB1	26	P04280
DLLGSPTLPDGTNNP	ZFP36L1	236	Q07352
PPPPSSSLSGQQTEQ	ZFHX4	3121	Q86UP3
PQGGPPISITNAATA	ZFHX2	2526	Q9C0A1
GNQGLPPPGLTISNS	MITF	266	O75030
NGQPQPDNVLSTGPT	SAGE1	166	Q9NXZ1
NSQPAPGNILSTAPP	SAGE1	636	Q9NXZ1
QVEPLPPTQQSSGSA	PTGIR	356	P43119
GESSDQGPRTPTQPL	TNS1	1096	Q9HBL0
PAEPGPLQPSTQGQS	TROAP	616	Q12815
QIPQPLPSQSSGENG	ARHGAP31	1211	Q2M1Z3
PTAPGGASQSNIVSP	UNQ9370/PRO34162	81	Q6UXP9
SPEPLGLPQSQSAQA	PPP6R1	846	Q9UPN7
GLPQSQSAQALTPPP	PPP6R1	851	Q9UPN7
QSAQALTPPPIPNGS	PPP6R1	856	Q9UPN7
QPDTPQPAAPSNGIT	ZDHHC14	331	Q8IZN3
PQEGTAPGICTSPQS	ZIM2	306	Q9NZV7
GDSLQPTGTSQPVQG	ZNF536	1206	O15090
PTGTSQPVQGLVSPL	ZNF536	1211	O15090
TSSPPQQLQSPSPGN	ZCCHC14	201	Q8WYQ9
LTPLSQPGPSSNIIG	TMEM245	686	Q9H330
QSSVSGSLVPGIQPP	UBN1	926	Q9NPG3
TSPVPTLPQVGNSGD	ZKSCAN7	201	Q9P0L1
LSSPQPLPLGASAQG	TEX33	46	O43247
SQQLLSQAGPSNPPG	WNK2	1401	Q9Y3S1
ATEGNATSPPQNPPT	ABI3BP	821	Q7Z7G0
GQVLSPSQPSDPGVL	SIGLEC10	396	Q96LC7
PGSAPSNIGLNDPSI	TUT4	1516	Q5TAX3
LSIPPQSPDQINGES	ARHGAP21	1911	Q5T5U3
GEPLVSSQSGQSPPE	ZNF335	371	Q9H4Z2
LNPTPGSNAISDVPG	PTPRC	136	P08575
QTPQGTFLVGQPSPQ	YEATS2	856	Q9ULM3
PSQGIPQGASTTPQA	TMEM108	371	Q6UXF1
SGTSDTGSLPPNLQP	THPO	276	P40225
QGPQPTLSVGQESSS	VPS13D	2131	Q5THJ4
VQSQTNGGPSPTPKA	LRFN4	556	Q6PJG9
APTSQQPEPVLGLGS	NACAD	1176	O15069